These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
¨
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Ordinary Shares
|
|
The NASDAQ Global Select Market
|
|
U.S. GAAP
x
|
International Financial Reporting Standard as
|
Other
¨
|
|
Issued by the International Accounting Standards
|
||
|
Board
¨
|
|
INTRODUCTION
|
|||
|
PART I
|
4
|
||
|
Item 1.
|
Identity of Directors, Senior Management and Advisors
|
4
|
|
|
Item 2.
|
Offer Statistics and Expected Timetable
|
4
|
|
|
Item 3.
|
Key Information
|
4
|
|
|
Item 4.
|
Information on the Company
|
28
|
|
|
Item 5.
|
Operating and Financial Review and Prospects
|
48
|
|
|
Item 6.
|
Directors, Senior Management, and Employees
|
66
|
|
|
Item 7.
|
Major Shareholders and Related Party Transactions
|
75
|
|
|
Item 8.
|
Financial Information
|
77
|
|
|
Item 9.
|
The Offer and Listing
|
78
|
|
|
Item 10.
|
Additional Information
|
80
|
|
|
Item 11.
|
Quantitative and Qualitative Disclosures About Market Risk
|
86
|
|
|
Item 12.
|
Description of Securities Other than Equity Securities
|
87
|
|
|
|
|||
|
PART II
|
88
|
||
|
Item 13.
|
Defaults, Dividend Arrearages, and Delinquencies
|
88
|
|
|
Item 14.
|
Material Modifications to the Rights of Security Holders and Use of Proceeds
|
88
|
|
|
Item 15.
|
Controls and Procedures
|
88
|
|
|
Item 16A.
|
Audit Committee Financial Expert
|
91
|
|
|
Item 16B.
|
Code of Ethics
|
91
|
|
|
Item 16C.
|
Principal Accountant Fees and Services
|
92
|
|
|
Item 16D.
|
Exemption from the Listing Standards for Audit Committees
|
92
|
|
|
Item 16E
|
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
|
92
|
|
|
Item 16F
|
|
Change in registrant’s certifying accountant
|
92
|
|
|
|||
|
PART III
|
94
|
||
|
Item 17.
|
Financial Statements
|
94
|
|
|
Item 18.
|
Financial Statements
|
94
|
|
|
Item 19.
|
Exhibits
|
94
|
|
|
|
|||
|
EX-1.1 CEO CERTIFICATION
|
|||
|
EX-1.2 CFO CERTIFICATION
|
|||
|
EX-1.3 CEO CERTIFICATION PURSUANT TO SECTION 906
|
|||
|
EX-1.4 CFO CERTIFICATION PURSUANT TO SECTION 906
|
|||
|
EX-1.5 CONSENT OF BDO CHINA TO S-8 and S-3
|
|||
|
EX-1.6 CONSENT OF BDO HONG KONG TO S-8 and S-3
|
|||
|
|
o
|
“we,” “us,” “our company,” “our,” the “Company” and “Origin” refer to Origin Agritech Limited and, in the context of describing our operations, also include State Harvest Holdings Limited and the following, which are collectively described in this Annual Report as “our PRC Operating Companies”: Beijing Origin State Harvest Biotechnology Limited, or Origin Biotechnology and its subsidiary Shandong Kunfeng or Origin Kunfeng, Beijing Origin Seed Limited, or Beijing Origin, and its five subsidiaries, Changchun Origin Seed Technology Development Limited, or Changchun Origin, Henan Origin Cotton Technology Development Limited, or Henan Origin, Denong Zhengcheng Seed Limited, or Denong, Jilin Changrong High-tech Seed Limited, or Jilin Changrong and Linze Origin Seed Limited, or Linze Origin, Xinjiang Originbo Seed Limited, or Xinjiang Origin. On July 4, 2011, Jilin Changrong has been liquidated and no longer exists as an entity;
|
|
|
o
|
“last year,” “fiscal year 2011,” “the year ended September 30, 2011” and “the fiscal year ended September 30, 2011” refer to the twelve months ended September 30, 2011, which is the period covered by this Annual Report;
|
|
|
o
|
all references to “Renminbi,” “RMB” or “yuan” are to the legal currency of China; all references to “U.S. dollars,” “dollars,” “$” or “US$” are to the legal currency of the United States. Any discrepancies in any table between totals and sums of the amounts listed are due to rounding.
The translation of Renminbi amounts into United States dollar amounts has been made for the convenience of the reader.
Such translation amounts should not be construed as representations that the Renminbi amounts could be readily converted into United States dollar amounts at that rate or any other rate;
|
|
|
o
|
“China” or “PRC” refers to the People’s Republic of China, excluding Taiwan, Hong Kong, and Macau;
|
|
|
o
|
“Hong Kong” refers to the Hong Kong Special Administrative Region of the People’s Republic of China; and
|
|
|
o
|
“shares” and “ordinary shares” refer to our ordinary shares, “preferred shares” refers to our preferred shares.
|
|
|
o
|
our goals and strategies, including how we implement our goals and strategies;
|
|
|
o
|
our expectations for our future business and product development, business prospects, results of business operations or any seed production operations, and current financial condition;
|
|
|
o
|
expected changes in our margins and certain costs or expenditures, inclusive of changes in our product costs;
|
|
|
o
|
our future pricing strategies or pricing policies;
|
|
|
o
|
our ability to successfully anticipate market demand for crop seeds in our market and plan our volume and product mix;
|
|
|
our ability to fit acquisitions into our growth strategies to generate sufficient value to justify their cost;
|
|
|
o
|
our plans for development of seed or technology internally, including our ability to successfully develop, produce, receive regulatory approval for and distribute proprietary seed products;
|
|
|
o
|
our expectations regarding our need to produce seeds and other biotechnology under licenses from third parties, and production results of our contracted farming production base;
|
|
|
o
|
the future development of agricultural biotechnology as a whole and the impact of genetically modified crop seeds in our industry;
|
|
|
o
|
the scope and impact of the governing and regulatory policies and laws regarding genetically modified seed products in China, and our ability to apply for and receive necessary approvals and to develop, produce, market and distribute genetically modified crop seeds;
|
|
|
o
|
compliance with government registration and regulation, including environmental regulations relating to our seed production and our chemical operations;
|
|
|
o
|
compliance with environmental regulatory standards relating to our chemical products;
|
|
|
o
|
our plans to license or co-develop any seed product or technology;
|
|
|
o
|
our plans regarding any future business combination or business acquisition;
|
|
|
o
|
PRC and other international governmental policies and regulations relating to the crop seed industry;
|
|
|
o
|
our plans to expand our business level or corporate level operations and product offerings;
|
|
|
o
|
the likelihood of recurrence of accounting charges or impairments;
|
|
|
o
|
expected changes in our sources of revenue and income base from our business operations or other sources;
|
|
|
o
|
competition in the crop seed industry in China and other international markets;
|
|
|
o
|
the future development of the crop seed industry in China and other international markets;
|
|
|
o
|
our plans for current staffing requirements, research and development and regional business focus;
|
|
|
o
|
our ability to successfully raise capital to accommodate growing company needs under acceptable terms or acceptable share price and at reasonable cost; and
|
|
|
o
|
the adequacy of our facilities or seed production for our future operations.
|
|
|
o
|
changing interpretations of generally accepted accounting principles and the adoption or use of international accounting standards in the future;
|
|
|
o
|
outcomes of PRC and international government reviews, inquiries, investigations and related litigation;
|
|
|
o
|
continued compliance with the government regulations of the PRC and other governments;
|
|
|
o
|
legislative and regulatory environments, requirements or changes adversely affecting the businesses in which we and our PRC operating companies are engaged;
|
|
|
o
|
fluctuations in the PRC or international customer demand;
|
|
|
o
|
management of the growth of our business and introduction of genetically modified products and chemical products;
|
|
|
o
|
timing of approval, production, and market acceptance of new products, inclusive of chemical products and genetically modified products;
|
|
|
o
|
general economic conditions in the PRC and worldwide; and
|
|
|
o
|
geopolitical events and regulatory changes.
|
|
(in thousands,
|
For the year ended
|
|||||||||||||||||||||||
|
except share data)
|
September 30,
|
|||||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||||||
|
RMB
|
RMB
|
RMB
|
RMB
|
RMB
|
USD
|
|||||||||||||||||||
|
Consolidated statement of income and comprehensive income data:
|
|
|
|
|
|
|
||||||||||||||||||
|
Net revenues
|
489,379 | 513,490 | 592,492 | 584,860 | 567,434 | 89,316 | ||||||||||||||||||
|
Cost of revenues
|
(462,852 | ) | (404,795 | ) | (392,842 | ) | (353,587 | ) | (371,592 | ) | (58,498 | ) | ||||||||||||
|
Gross profit
|
26,527 | 108,695 | 199,650 | 231,273 | 195,842 | 30,818 | ||||||||||||||||||
|
Selling and marketing
|
(57,994 | ) | (53,203 | ) | (55,648 | ) | (52,227 | ) | (56,831 | ) | (8,943 | ) | ||||||||||||
|
General and administrative
|
(92,246 | ) | (73,355 | ) | (64,833 | ) | (78,708 | ) | (86,747 | ) | (13,651 | ) | ||||||||||||
|
Research and development
|
(28,441 | ) | (24,513 | ) | (33,473 | ) | (38,356 | ) | (44,771 | ) | (7,045 | ) | ||||||||||||
|
Other income, net
|
1,312 | 628 | 1,991 | 2,340 | 5,120 | 806 | ||||||||||||||||||
|
Total operating expenses
|
(177,369 | ) | (150,443 | ) | (151,963 | ) | (166,951 | ) | (183,229 | ) | (28,833 | ) | ||||||||||||
|
Income (loss) from operations
|
(150,842 | ) | (41,748 | ) | 47,687 | 64,322 | 12,613 | 1,985 | ||||||||||||||||
|
Interest income
|
10,942 | 5,199 | 2,036 | 1,634 | 1,771 | 279 | ||||||||||||||||||
|
Interest expenses
|
(21,697 | ) | (36,939 | ) | (16,784 | ) | (8,539 | ) | (1,469 | ) | (231 | ) | ||||||||||||
|
Loss on repurchase of convertible notes
|
- | - | (51,101 | ) | - | - | - | |||||||||||||||||
|
Equity in earnings/ gain on disposal of associated company
|
(669 | ) | 7,702 | 4,669 | 18,253 | 1,616 | 254 | |||||||||||||||||
|
Loss on liquidation of subsidiary
|
- | - | - | - | (13,582 | ) | (2,137 | ) | ||||||||||||||||
|
Changes in the fair value of embedded derivatives
|
12,601 | 20,229 | 3,300 | - | - | - | ||||||||||||||||||
|
Income (loss) before income taxes
|
(149,665 | ) | (45,557 | ) | (10,193 | ) | 75,670 | 949 | 150 | |||||||||||||||
|
Income benefit (tax)
|
(49 | ) | 3,995 | (11,732 | ) | (9,319 | ) | (13,730 | ) | (2,160 | ) | |||||||||||||
|
Income (loss) before non-controlling interests
|
(149,616 | ) | (41,562 | ) | (21,925 | ) | 66,351 | (12,781 | ) | (2,010 | ) | |||||||||||||
|
Non-controlling interests
|
(13,584 | ) | (1,724 | ) | 18,892 | 17,298 | (10,298 | ) | (1,620 | ) | ||||||||||||||
|
Net income (loss)
|
(163,200 | ) | (43,286 | ) | (40,817 | ) | 49,053 | (23,079 | ) | (3,630 | ) | |||||||||||||
|
Income (loss) attributable to ordinary shareholders
|
(163,200 | ) | (43,286 | ) | (40,817 | ) | 49,053 | (23,079 | ) | (3,630 | ) | |||||||||||||
|
Net income (loss) per share:
|
||||||||||||||||||||||||
|
Basic
|
(7.01 | ) | (1.88 | ) | (1.77 | ) | 2.12 | (1.00 | ) | (0.16 | ) | |||||||||||||
|
Diluted
|
(7.01 | ) | (1.88 | ) | (1.77 | ) | 2.10 | (1.00 | ) | (0.16 | ) | |||||||||||||
|
Shares used in computation:
|
||||||||||||||||||||||||
|
Basic
|
23,268,062 | 22,987,270 | 23,013,692 | 23,189,464 | 23,072,895 | 23,072,895 | ||||||||||||||||||
|
Diluted
|
23,268,062 | 22,987,270 | 23,013,692 | 23,337,265 | 23,072,895 | 23,072,895 | ||||||||||||||||||
|
30-Sep
|
30-Sep
|
30-Sep
|
30-Sep
|
30-Sep
|
||||||||||||||||||||
|
(in thousands)
|
2007
|
2008
|
2009
|
2010
|
2011
|
|||||||||||||||||||
|
RMB
|
RMB
|
RMB
|
RMB
|
RMB
|
USD
|
|||||||||||||||||||
|
Consolidated balance sheet data:
|
|
|
|
|
|
|
||||||||||||||||||
|
Cash and cash equivalents
|
162,314 | 102,263 | 121,255 | 299,672 | 129,942 | 20,448 | ||||||||||||||||||
|
Current working capital (2)
|
294,976 | 77,966 | (33,533 | ) | 67,650 | (21,753 | ) | (3,423 | ) | |||||||||||||||
|
Total assets
|
1,110,983 | 894,296 | 824,544 | 935,011 | 818,382 | 128,780 | ||||||||||||||||||
|
Deferred revenue
|
23,238 | 34,848 | 18,280 | 23,111 | 19,812 | 3,118 | ||||||||||||||||||
|
Total current liabilities
|
499,347 | 487,576 | 546,822 | 596,611 | 532,571 | 83,805 | ||||||||||||||||||
|
Total liabilities
|
765,291 | 591,048 | 546,822 | 606,037 | 532,571 | 83,805 | ||||||||||||||||||
|
Non-controlling interests
|
48,775 | 39,224 | 51,389 | 57,089 | 26,774 | 4,213 | ||||||||||||||||||
|
Total shareholders’ equity
|
296,917 | 264,024 | 226,333 | 271,885 | 259,037 | 40,762 | ||||||||||||||||||
|
Average (1)
|
High
|
Low
|
Period-
end
|
|||||||||||||
|
2007
|
7.6947 | 7.9168 | 7.4928 | 7.4928 | ||||||||||||
|
2008
|
7.0578 | 7.5158 | 6.78 | 6.7899 | ||||||||||||
|
2009
|
6.8328 | 6.8527 | 6.8201 | 6.8262 | ||||||||||||
|
2010
|
6.812 | 6.8287 | 6.6936 | 6.7011 | ||||||||||||
|
2011
|
6.4576 | 6.6349 | 6.3165 | 6.3549 | ||||||||||||
|
June
|
6.4778 | 6.4892 | 6.4683 | 6.4716 | ||||||||||||
|
July
|
6.4614 | 6.4748 | 6.4426 | 6.4442 | ||||||||||||
|
August
|
6.409 | 6.4451 | 6.3849 | 6.8105 | ||||||||||||
|
September
|
6.3833 | 6.3982 | 6.3549 | 6.3549 | ||||||||||||
|
October
|
6.3566 | 6.3762 | 6.3233 | 6.3233 | ||||||||||||
|
November
|
6.3408 | 6.3587 | 6.3165 | 6.3482 | ||||||||||||
|
December
|
6.3341 | 6.3396 | 6.3297 | 6.3396 | ||||||||||||
|
(1)
|
Annual averages are calculated from month-end rates. Monthly averages are calculated using the average of the daily rates during the relevant period.
|
|
|
Year Ended
September 30,
2009
|
Year Ended
September 30,
2010
|
Year Ended
September 30,
2011
|
|||||||||
|
Revenue resulting from licensed hybrid seeds
|
$
|
50,513,090
|
$
|
49,331,898
|
$
|
52,045,527
|
||||||
|
Percentage of our total seed revenue resulting from licensed hybrid seeds
|
58.22
|
% |
58.51
|
% |
58.27
|
% | ||||||
|
Revenue resulting from internally developed proprietary hybrid seeds
|
$
|
36,248,141
|
$
|
34,982,517
|
$
|
37,270,373
|
||||||
|
|
Year Ended
September 30,
2009
|
Year Ended
September 30,
2010
|
Year Ended
September 30,
2011
|
|||||||||
|
Percentage of our total seed revenue resulting from internally developed proprietary hybrid seeds
|
41.78 | % | 41.49 | % | 41.73 | % | ||||||
|
|
Year Ended
September 30,
2009
|
Year Ended
September 30,
2010
|
Year Ended
September 30,
2011
|
|||||||||
|
Revenue resulting from hybrid seeds developed and produced under our license agreements with the significant licensors
|
$
|
20,378,080
|
$
|
25,395,082
|
$
|
33,509,070
|
||||||
|
Percentage of our total seed revenue resulting from hybrid seeds developed and produced under our license agreements with the significant licensors
|
23.49
|
% |
30.12
|
% |
37.52
|
% | ||||||
|
|
o
|
uncertain and continued market acceptance for our product extensions and our services;
|
|
|
o
|
the evolving nature of the crop seed industry in the PRC, where significant consolidation may occur, leading to the formation of companies which may be better able to compete with us than is currently the case;
|
|
|
o
|
changing competitive conditions, technological advances or customer preferences could harm sales of our products or services
;
|
|
|
o
|
maintaining our competitive position in the PRC and competing with Chinese and international companies, many of which have longer operating histories and greater financial resources than us;
|
|
|
o
|
maintaining our current licensing arrangements and entering into new ones to expand our product offerings;
|
|
|
o
|
continuing to offer commercially successful products to attract and retain a larger base of direct customers and ultimate users;
|
|
|
o
|
retaining access to the farmland we currently use for production of our products and obtaining access to additional farmland for expansion;
|
|
|
o
|
continuing our existing arrangements with production farms that grow our seed products and entering into new arrangements with additional production farms;
|
|
|
o
|
maintaining effective control of our costs and expenses; and
|
|
|
o
|
retaining our management and skilled technical staff and recruiting additional key employees.
|
|
o
|
Dr. Gengchen Han, our Chairman of the Board, Chief Executive Officer, and President.
|
|
|
o
|
increasing the PRC operating subsidiaries’ tax liability without reducing Origin Biotechnology’s tax liability, which could further result in late payment fees and other penalties to our PRC operating subsidiaries for under-paid taxes; or
|
|
|
o
|
limiting Origin Biotechnology’s ability to maintain preferential tax treatment and government financial incentives, which, if the transfer pricing adjustment is significant, could result in Origin Biotechnology failing to qualify for those preferential tax treatments and government financial incentives.
|
|
|
o
|
require us to dedicate a portion of our near term cash flows from operations and other capital resources to debt service;
|
|
|
o
|
make it difficult for us to obtain necessary financing in the future for working capital, acquisitions or other purposes on favorable terms, if at all;
|
|
|
o
|
make us more vulnerable to industry downturns and competitive pressures; and
|
|
|
o
|
limit our flexibility in planning for, or reacting to changes in, our business.
|
|
|
o
|
on January 24, 2006, Beijing Origin and Jilin Jinong Hi-tech Limited jointly established Jilin Changrong, with Beijing Origin holding 34.77% of Jilin Changrong. On April 11, 2007, Beijing Origin acquired an additional 9.18% equity interest in Jilin Changrong for RMB22.04 million (US$2.94 million). On December 15, 2009, Beijing Origin acquired an additional 10% stake in Jilin Changrong for R
MB24.00 million (US$3.58 million)
bringing Beijing Origin’s total direct ownership to 53.95% and our combined direct and indirect ownership to 61.66%. Jilin Changrong engages in the research, development, production, sale and distribution of hybrid corn in the northeast region of China; On July 4, 2011, Jilin Changrong has been liquidated and no longer exists as an entity. Origin will continue to hold 23% of the Jinong Hi-tech.
|
|
|
o
|
on January 24, 2006, Beijing Origin acquired a 52.21% controlling interest in Denong. On October 8, 2006, Beijing Origin acquired an additional 42.42% equity interest in Denong, and together with a 2.99% equity interest acquired on December 25, 2006, with a 0.25% equity interest acquired on January 20, 2010 bringing its total ownership to approximately 97.87%, for which it paid total consideration of approximately RMB54.76 million (US$7.31 million). Denong is a developer, producer and marketer of hybrid rice, cotton, corn and canola, principally in the southwest region of China; and
|
|
|
o
|
on October 19, 2006, Beijing Origin acquired a 19% interest in Biocentury, a leading company engaged in GM cotton research, seed production, and marketing in China, for RMB16.7 million (US$2.23 million). After acquiring a 7% interest in 2004 and an 8% interest in 2005, Beijing Origin now holds 34% of Biocentury. On May 27, 2010, Beijing Origin divested a 34% interest in Biocentury, for RMB60.0 million (US$8.95 million).
|
|
|
·
|
on June12, 2010, Origin Biotechnology acquired a 80% interest in Shandong Kunfeng, a company engaged in agricultural chemical production and marketing in China, for RMB14.96 million (US$2.23 million).
|
|
|
·
|
In May 2011, Origin entered into a licensing agreement for GMO trait development to develop high-yielding corn varieties incorporating the glyphosate-resistant and Bt- traits of our products, which are protected by patents issued in the PRC and the United States.
|
|
|
·
|
In July 2011, Origin Agritech Limited acquired a 51% interest in Xinjiang Origin, a company engaged in producing, processing, packaging and selling high quality seed products in China for RMB100 million (USD15.74million), paid in capital RMB 40million (USD$6.29million) as of September 30, 2011.
|
|
For the year ended
September 30,
|
For the year ended
September 30,
|
For the year ended
September 30,
|
For the year ended
September 30,
|
||
|
2008
|
2009
|
2010
|
2011
|
||
|
RMB
|
RMB
|
RMB
|
RMB
|
||
|
19.66 million
|
RMB18.80 million
|
15.84 million
|
51.66 million
|
||
|
(US$2.90 million)
|
(US$2.75 million)
|
(US$2.58 million)
|
(US$8.13 million)
|
|
Year Ended
September 30,
2008
|
Year Ended
September 30,
2009
|
Year Ended
September 30,
2010
|
Year Ended
September 30,
2011
|
|||||||||||||
|
Revenue resulting from
licensed hybrid seeds
|
US$ | 52,023,150 | US$ | 50,513,090 | US$ | 49,331,898 | US$ | 52,045,527 | ||||||||
|
Percentage of our total seed revenue resulting from licensed hybrid seeds
|
68.79 | % | 58.22 | % | 58.51 | % | 58.27 | % | ||||||||
|
Revenue
resulting
from internally developed proprietary hybrid seeds
|
US$ | 23,603,275 | US$ | 36,248,141 | US$ | 34,928,517 | US$ | 37,270,373 | ||||||||
|
Percentage of our total seed revenue resulting from internally developed proprietary hybrid seeds
|
31.21 | % | 41.78 | % | 41.49 | % | 41.73 | % | ||||||||
|
Year
|
|
Varieties of Seed Products
|
|
|||||||||||
|
|
|
Corn
|
|
Cotton
|
|
Rice
|
|
Canola
|
|
Total
|
|
|||
|
2008
|
47
|
16
|
57
|
15
|
135
|
|||||||||
|
2009
|
46
|
13
|
53
|
7
|
119
|
|||||||||
|
2010
|
45
|
10
|
55
|
7
|
117
|
|||||||||
|
2011
|
45
|
12
|
57
|
11
|
125
|
|||||||||
|
Year
|
|
Revenues*
|
||||||||
|
|
|
Corn
|
|
Cotton
|
|
Rice
|
|
Canola
|
||
|
RMB
|
RMB
|
RMB
|
RMB
|
|||||||
|
Year ended September 30, 2008
|
364,843,855
|
16,663,187
|
106,636,187
|
24,855,519
|
||||||
|
Year ended September 30, 2009
|
414,625,462
|
9,917,053
|
125,134,572
|
42,747,377
|
||||||
|
Year ended September 30, 2010
|
428,863,503
|
11,996,313
|
84,211,605
|
38,515,030
|
||||||
|
Year ended September 30, 2011
|
419,467,551
|
18,899,783
|
91,778,481
|
16,833,211
|
||||||
|
For the year ended
|
For the year ended
|
For the year ended
|
For the year
|
||||||||||
|
September 30,
|
September 30,
|
September 30,
|
ended September 30
|
||||||||||
|
2008
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
|||||||||||
|
RMB
|
24,512,551 |
RMB
|
33,473,117 |
RMB
|
38,355,325 |
RMB
|
44,771,289 | ||||||
|
US
|
(3,610,149 | ) |
US
|
(4,901,613 | ) |
US
|
(5,723,825 | ) |
US
|
(7,045,160 | ) | ||
|
No.
|
Name of Variety
|
Name of Seed
|
||
|
Product
|
||||
|
1
|
AoTian 8210
|
Corn
|
||
|
2
|
Ao Yu 1
|
Corn
|
||
|
3
|
Ao Yu 20
|
Corn
|
||
|
4
|
Ao Yu 2
|
Corn
|
||
|
5
|
Ao Yu 3007
|
Corn
|
||
|
6
|
Ao Yu 3101
|
Corn
|
||
|
7
|
Ao Yu 3102
|
Corn
|
||
|
8
|
Ao Yu 3111
|
Corn
|
||
|
9
|
Ao Yu 3118
|
Corn
|
||
|
10
|
Ao Yu 3202
|
Corn
|
||
|
11
|
Ao Yu 3206
|
Corn
|
||
|
12
|
Ao Yu 7
|
Corn
|
||
|
13
|
Ao Yu 28
|
Corn
|
||
|
14
|
Ao Yu 4
|
Corn
|
||
|
15
|
Ao Yu 5102
|
Corn
|
||
|
16
|
Ao Yu 5
|
Corn
|
||
|
17
|
Ji Dan262
|
Corn
|
||
|
18
|
Ji Dan29
|
Corn
|
||
|
19
|
Ji Dan413
|
Corn
|
||
|
20
|
Ao Yu 12
|
Corn
|
||
|
21
|
Ji Si 8
|
Corn
|
||
|
22
|
Ao Yu 21
|
Corn
|
||
|
23
|
Yu Ao 6
|
Corn
|
||
|
24
|
Ao Yu 3214
|
Corn
|
||
|
25
|
Ao Yu 3628
|
Corn
|
||
|
26
|
Gang You 99-14
|
Rice
|
||
|
27
|
Nei Xiang You 9
|
Rice
|
||
|
28
|
Shan You 456
|
Rice
|
||
|
29
|
Liang You 456
|
Rice
|
||
|
30
|
De Xiang Zao 4
|
Rice
|
||
|
31
|
De Nong 108
|
Rice
|
||
|
32
|
De Nong 88
|
Rice
|
||
|
33
|
De Liang You 9
|
Rice
|
||
|
34
|
Fei You 463
|
Rice
|
||
|
35
|
Zhong 9 You 1254
|
Rice
|
||
|
36
|
De E Liang You 1
|
Rice
|
||
|
37
|
Zheng Cheng 456
|
Rice
|
||
|
38
|
De You 1254
|
Rice
|
||
|
39
|
Zhu Liang You4290
|
Rice
|
||
|
40
|
Nei Xiang You 18
|
Rice
|
||
|
41
|
Zhong You 463
|
Rice
|
||
|
42
|
Fei You 98
|
Rice
|
||
|
43
|
Zhong You 4202
|
Rice
|
||
|
44
|
Zhu Liang You 312
|
Rice
|
||
|
45
|
De You 13
|
Canola
|
||
|
46
|
Ao Mian 16
|
Cotton
|
||
|
47
|
De Mian 206F1
|
Cotton
|
||
|
48
|
Ao Mian 28
|
Cotton
|
||
|
49
|
Ao Mian 6
|
Cotton
|
||
|
50
|
Ao Mian 618
|
Cotton
|
||
|
51
|
Ao Mian 8
|
Cotton
|
||
|
52
|
Ao Mian 9
|
Cotton
|
|
Varieties of
Corn Seeds
|
2009 Sales
|
2010 Sales
|
2011Sales
|
|||||||||
|
LinAo1
|
3.79 | % | 3.96 | % | 4.41 | % | ||||||
|
AoYu 17
|
1.11 | % | 0.82 | % | 0.90 | % | ||||||
|
Liyu 16
|
12.99 | % | 14.76 | % | 16.81 | % | ||||||
|
AoYu 19
|
0.00 | % | 0.00 | % | 0.00 | % | ||||||
|
Liyu 26
|
0.30 | % | 0.57 | % | 0.38 | % | ||||||
|
Liyu 35
|
8.42 | % | 10.58 | % | 12.81 | % | ||||||
|
Liyu 37
|
0.00 | % | 0.00 | % | 0.38 | % | ||||||
|
Total
|
26.61 | % | 30.69 | % | 35.69 | % | ||||||
|
|
(i)
|
producing and distributing high-quality seed products, initially under third-party licenses and, over time, increasingly internally developed proprietary seeds, to deliver superior value to our distributor-customers and their farmer-customers;
|
|
|
(ii)
|
devising a process for obtaining regulatory approvals for new crop seeds (a Chinese legal requirement) that is efficient and effective;
|
|
|
(iii)
|
establishing a broad network of producer-farmers in several regions to participate in the seed development process and to produce approved crop seeds for commercial distribution;
|
|
|
(iv)
|
creating an effective distribution system using a relatively small network of primary distributors, only one in each county with exclusive territories, with which we can deal directly and efficiently which, in turn, develop their own secondary distribution network to reach out directly to the consumer- farmers. This distribution network is not only a means for securing and fulfilling orders, but acts as a conduit for our marketing and technical support activities;
|
|
|
(v)
|
relying on a number of marketing activities to retain existing customers and attract new ones. These marketing activities include:
|
|
|
-
|
a demonstration program that provides technical assistance to customers regarding the correct seed choice and proper cultivation methods;
|
|
|
-
|
a database of over 15 million customers that we use to keep repeat sales at a high level, an important component of revenue growth; and
|
|
(vi)
|
delivering service and technical support to customers throughout the growing season for its products. End-user customers can contact us through a dedicated call center that handles up to 1,000 calls per day. Field service representatives are dispatched within 48 hours of a customer’s request for help.
|
|
|
o
|
the Ministry of Agriculture and its local authorities;
|
|
|
o
|
the Ministry of Commerce and its local authorities;
|
|
|
o
|
SAFE and its local authorities;
|
|
|
o
|
the State Administration of Industry and Commence and its local authorities; and
|
|
|
o
|
the State Environmental Protection Administration; and
|
|
|
o
|
the State Administration of Taxation, and the Local Taxation Bureau.
|
|
|
o
|
to obtain a national distribution license, the licensee must have a registered capital of at least RMB30 million (approximately US$4,418,327);
|
|
|
o
|
to obtain a provincial license to distribute hybrid seed varieties, the licensee must have a registered capital of at least RMB5 million (approximately US$736,388); and
|
|
|
o
|
to obtain a provincial license to distribute non-hybrid seed varieties, the licensee must have a registered capital of at least RMB1 million (approximately US$147,278).
|
|
|
o
|
submit the application to the provincial variety authorization committee;
|
|
|
o
|
undergo two growing seasons of monitored growth in at least five different locations in the province. Seeds submitted for testing are planted together with control seeds, which is typically the most popular seed with farmers in the testing locations. Only seeds that have an increased yield of 8% or higher versus the control seeds and that rank in the top six among all seeds then being tested are cleared to proceed to the second year of testing, during which the results of the initial test season must be confirmed; and
|
|
|
o
|
go through one successful growing season of trial production, also in at least five different locations. If successful, a provincial examination certificate is granted and a public announcement is made.
|
|
|
o
|
submit the application to the national variety authorization committee;
|
|
|
o
|
complete two growing seasons of monitored production in at least five different locations. Only seeds that have 8% or higher yield compared to control seeds and that also rank in the top six among all seeds being tested in that cycle can proceed to the second year of testing; and
|
|
|
o
|
complete one successful growing season of trial production in at least five different locations.
|
|
Name
|
|
Place of incorporation
(or establishment)/operation
|
|
Percentage
of ownership
|
|
State Harvest
|
British Virgin Islands
|
100% owned by Origin
|
||
|
Origin Biotechnology
|
Haidian District, Beijing, PRC
|
100% owned by State Harvest
|
||
|
Beijing Origin
|
Haidian District, Beijing, PRC
|
97.96% controlled by State Harvest
|
||
|
Henan Origin
|
Zhengzhou, Henan Province, PRC
|
92.04% owned by Beijing Origin
|
||
|
Changchun Origin
|
Changchun, Jilin Province, PRC
|
99% owned by Beijing Origin
|
||
|
Denong
|
Chengdu, Sichuan Province, PRC
|
97.87% owned by Beijing Origin
|
||
|
Liyu
|
Shijiazhuang, Hebei Province, PRC
|
30% owned by Beijing Origin
|
||
|
Linze Origin
|
Linze, Gansu Province, PRC
|
100% owned by Beijing Origin
|
||
|
Shandong Kunfeng
|
Jinan, Shandong Province, PRC
|
80% owned by Beijing Biotechnology
|
||
|
Xinjiang Origin
|
Jinbo City, Xinjiang Province, PRC
|
51% owned by Beijing Origin
|
|
PRC Operating Company
|
Consigning Owner
|
% of Shares
Consigned
|
||||
|
Beijing Origin
|
Gengchen Han
|
34.4 | % | |||
|
Yasheng Yang
|
28.675 | % | ||||
|
Liang Yuan
|
25.8 | % | ||||
|
Yuping Zhao
|
3.995 | % | ||||
|
Weidong Zhang
|
3.13 | % | ||||
|
Weicheng Chen
|
1.96 | % | ||||
| 97.96 | % | |||||
|
Changchun Origin
|
Beijing Origin
|
99.0 | % | |||
|
Gengchen Han
|
1.0 | % | ||||
| 100.0 | % | |||||
|
Henan Origin
|
Beijing Origin
|
90.0 | % | |||
|
Yingli Zhang
|
4.08 | % | ||||
|
Yasheng Yang
|
3.88 | % | ||||
| 97.96 | % | |||||
|
1.
|
Laboratory Research: is defined by genetic manipulations and research work conducted under a control system within laboratory.
|
|
2.
|
Intermediate Testing Phase: signifies a small scale test conducted under a regulated control system.
|
|
3.
|
Environmental Release Test: means medium scale test conducted under natural condition by taking relatively secure measures.
|
|
4.
|
Production Test: means relatively large scale test before production and application.
|
|
5.
|
Obtaining the safety certificate on genetically modified organisms.
|
|
|
o
|
our ability to strategically manage our growth and expansion, organically or through mergers and acquisitions. If we do not manage our growth effectively, our growth may slow and we may not be able to achieve or maintain profitability;
|
|
o
|
our ability to fit acquisitions into our growth strategies to generate sufficient value to justify their cost;
|
|
|
o
|
our ability to develop new products through research and development;
|
|
|
o
|
our ability to partner or joint venture for the creation of more advanced bio-technology products;
|
|
|
o
|
market fluctuations in the demand for and supply of crop seeds in China and our ability to anticipate market demand and adjust our volume and product mix to maximize revenues and maintain sufficiently high margins to achieve and maintain profitability;
|
|
|
o
|
our ability to continue to license or acquire crop seeds from third party developers and our ability to develop proprietary crop seeds;
|
|
|
o
|
our ability to continue to effectively market and distribute our core products through active agronomic assistance;
|
|
|
o
|
future consolidations in the crop seed industry in China may give rise to new or strengthened competitors;
|
|
|
o
|
the possibility that the crop seed industry in China may favor genetically modified seeds over hybrid seeds, and our ability to develop, produce, market, and sell such products;
|
|
|
o
|
the possibility of major natural disasters in China, which may have an adverse impact on our business and results of operation, as there is currently no agriculture insurance available in China against natural disasters;
|
|
|
o
|
the Chinese government’s continuing support for the growth and development of the agriculture sector;
|
|
|
o
|
the impact of Chinese regulation affecting our industry;
|
|
|
o
|
our benefits from certain government incentives including tax incentives, the expiration of which, or changes to which, could have an adverse effect on our operating results;
|
|
|
o
|
the possibility that excess supply of one or more of our products in our markets may drive down prices and reduce our margins, especially if we are unable to sufficiently differentiate our products from those of our competitors to allow us to charge higher prices; and
|
|
|
o
|
our ability to correctly estimate growers’ future needs, and match our product varieties and production levels to meet those needs.
|
|
For the year
|
For the year
|
For the year
|
For the year
|
|||||||||||||||||||||||||||||||||||||
|
Item
|
ended September 30
|
ended September 30
|
ended September 30
|
ended September 30
|
||||||||||||||||||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||||||||||||||||||||||
|
As %
|
As %
|
As %
|
As %
|
As %
|
||||||||||||||||||||||||||||||||||||
|
In thousands
RMB
|
of net
revenue
|
In thousands
RMB
|
of net
revenue
|
In thousands
RMB
|
of net
revenue
|
In thousands
RMB
|
of net
revenue
|
In thousands
RMB
|
of net
Revenue
|
|||||||||||||||||||||||||||||||
|
Consolidated statement of income and comprehensive income data:
|
||||||||||||||||||||||||||||||||||||||||
|
Revenues
|
489,379 | 100 | 513,490 | 100 | 592,492 | 100 | 584,860 | 100 | 567,594 | 100 | ||||||||||||||||||||||||||||||
|
Cost of revenues
|
(462,852 | ) | (94.58 | ) | (404,795 | ) | (78.83 | ) | (392,842 | ) | (66.30 | ) | (353,587 | ) | (60.46 | ) | (371,751 | ) | 65 | |||||||||||||||||||||
|
Gross profit
|
26,527 | 5.42 | 108,695 | 21.17 | 199,650 | 33.70 | 231,273 | 39.54 | 195,843 | 35 | ||||||||||||||||||||||||||||||
|
Selling and marketing
|
(57,994 | ) | (11.85 | ) | (53,203 | ) | (10.36 | ) | (55,648 | ) | (9.39 | ) | (52,227 | ) | (8.93 | ) | (56,831 | ) | (10.01 | ) | ||||||||||||||||||||
|
General and administrative
|
(92,246 | ) | (18.85 | ) | (73,355 | ) | (14.29 | ) | (64,833 | ) | (10.94 | ) | (78,708 | ) | (13.46 | ) | (86,748 | ) | (15.28 | ) | ||||||||||||||||||||
|
Research and development
|
(28,441 | ) | (5.81 | ) | (24,513 | ) | (4.77 | ) | (33,473 | ) | (5.65 | ) | (38,356 | ) | (6.56 | ) | (44,771 | ) | (7.89 | ) | ||||||||||||||||||||
|
Other income, net
|
1,312 | 0.27 | 628 | 0.12 | 1,991 | 0.34 | 2,340 | 0.40 | 5,120 | 0.90 | ||||||||||||||||||||||||||||||
|
Total operating expenses
|
(177,369 | ) | 36.24 | ) | (150,443 | ) | (29.30 | ) | (151,963 | ) | (25,65 | ) | (166,951 | ) | (28.55 | ) | (183,229 | ) | (32.28 | ) | ||||||||||||||||||||
|
Income from operations
|
(150,842 | ) | (30.82 | ) | (41,748 | ) | (8.13 | ) | 47,687 | 8.05 | 64,322 | 11.00 | 12,613 | 2.22 | ||||||||||||||||||||||||||
|
Interest income
|
10,942 | 2.24 | 5,199 | 1.01 | 2,036 | 0.34 | 1,634 | 0.28 | 1,771 | 0.31 | ||||||||||||||||||||||||||||||
|
Interest expenses
|
(21,697 | ) | (4.43 | ) | (36,939 | ) | (7.19 | ) | (16,784 | ) | (2.83 | ) | (8,539 | ) | (1.46 | ) | (1,469 | ) | (0.26 | ) | ||||||||||||||||||||
|
Loss on repurchase of convertible notes
|
- | - | - | - | ( 51,101 | ) | (8.62 | ) | - | - | - | - | ||||||||||||||||||||||||||||
|
Equity in earnings of associated company
|
(669 | ) | (0.14 | ) | 7,702 | 1.50 | 4,669 | 0.79 | 9,370 | 3.12 | 1,616 | 0.28 | ||||||||||||||||||||||||||||
|
Loss on liquidation of subsidiary
|
- | - | - | - | - | - | - | - | (13,582 | ) | (2.39 | ) | ||||||||||||||||||||||||||||
|
Changes in the fair value of embedded derivatives
|
12,601 | 2.57 | 20,229 | 3.94 | 3,300 | 0.56 | - | - | - | - | ||||||||||||||||||||||||||||||
|
Income before income taxes
|
(149,665 | ) | (30.58 | ) | (45,557 | ) | (8.87 | ) | (10,193 | ) | (1.72 | ) | 75,670 | 12.94 | 949 | 0.17 | ||||||||||||||||||||||||
|
Income tax
|
49 | 0.01 | 3,995 | 0.78 | (11,732 | ) | (1.98 | ) | (9,319 | ) | (1.59 | ) | (13,730 | ) | (2.42 | ) | ||||||||||||||||||||||||
|
Income before non-controlling interests
|
(149,616 | ) | (30.57 | ) | (41,562 | ) | (8.09 | ) | (21,925 | ) | (3.70 | ) | 66,351 | 11.34 | (12,781 | ) | (2.25 | ) | ||||||||||||||||||||||
|
Non-controlling interests
|
(13,584 | ) | (2.78 | ) | (1,724 | ) | (0.34 | ) | (18,892 | ) | (3.19 | ) | (17,298 | ) | (2.96 | ) | (10,298 | ) | (1.81 | ) | ||||||||||||||||||||
|
Net income
|
(163,200 | ) | (33.35 | ) | (43,286 | ) | (8.43 | ) | (40,817 | ) | (6.89 | ) | 49,053 | 8.39 | (23,079 | ) | (4.07 | ) | ||||||||||||||||||||||
|
Items
|
Revenues
|
Gross Margin
|
||||||||||||||||||||||
|
Year ended
September 30,
2011
|
Year ended
September 30,
2010
|
Growth
|
Year ended
September 30,
2011
|
Year ended
September 30,
2010
|
Growth
|
|||||||||||||||||||
|
RMB’000
|
RMB’000
|
|||||||||||||||||||||||
|
Hybrid Corn seeds*
|
409,134 | 421,420 | (2.92 | ) % | 40.26 | % | 49.65 | % | (18.91 | ) % | ||||||||||||||
|
Hybrid Rice seeds*
|
90,309 | 82,375 | 9.63 | % | 32.41 | % | 36.96 | % | (12.31 | ) % | ||||||||||||||
|
Hybrid Cotton seeds*
|
18,920 | 11,883 | 59.22 | % | 11.23. | % | 35.76. | % | (68.60 | ) % | ||||||||||||||
|
Hybrid Canola seeds*
|
16,833 | 38,106 | (55.83 | ) % | 58.67 | % | 63.05 | % | (6.95 | ) % | ||||||||||||||
|
Pesticides*
|
20,615 | 18,958 | 8.74 | % | 19.69 | % | 13.01 | % | 51.35 | % | ||||||||||||||
|
Other
|
2,572 | 1,143 | 125.02 | % | N/ A | N/ A | N/ A | |||||||||||||||||
|
Total normal sales*
|
558,383 | 573,885 | (2.70 | ) % | 38.08 | % | 47.15 | % | (19.24 | ) % | ||||||||||||||
|
Items
|
Revenues
|
Gross Margin
|
||||||||||||||||||||||
|
|
Year ended
September 30,
2010
|
Year ended
September 30,
2009
|
Growth
|
Year ended
September 30,
2010
|
Year ended
September 30,
2009
|
Growth
|
||||||||||||||||||
|
|
RMB’000
|
RMB’000
|
||||||||||||||||||||||
|
Hybrid Corn seeds*
|
421,420 | 411,405 | 2.44 | % | 49.65 | % | 40.60 | % | 22.29 | % | ||||||||||||||
|
Hybrid Rice seeds*
|
82,375 | 125,135 | (34.18 | )% | 36.96 | % | 16.50 | % | 124 | % | ||||||||||||||
|
Hybrid Cotton seeds*
|
11,883 | 9,917 | 19.83 | % | 35.76 | %. | 49.90 | % | (28.34 | )% | ||||||||||||||
|
Hybrid Canola seeds*
|
38,106 | 42,747 | (10.86 | )% | 63.05 | % | 41.99 | % | 50.16 | % | ||||||||||||||
|
Pesticides*
|
18,958 | N/A | N/A | 13.01 | % | N/A | N/A | |||||||||||||||||
|
Other
|
1,143 | 68 | N/ A | N/A | N/A | N/A | ||||||||||||||||||
|
Total normal sales*
|
573,885 | 589,272 | (2.62 | )% | 47.15 | % | 35.60 | % | 32.45 | % | ||||||||||||||
| Item | Year ended September 30 | |||||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
2011
|
|||||||||||||||||||
|
RMB
|
RMB
|
RMB
|
RMB
|
RMB
|
US$
|
|||||||||||||||||||
|
Net cash provided by Operating activities
|
(169,242 | ) | 57,198 | 208,883 | 298,604 | 24,794 | 3,901 | |||||||||||||||||
|
Net cash (used in) provided by investing activities
|
(90,948 | ) | 107,630 | (15,981 | ) | 15,105 | (141,642 | ) | (22,288 | ) | ||||||||||||||
|
Net cash used in by financing activities
|
283,774 | (212,025 | ) | (175,933 | ) | (136,359 | ) | (55,821 | ) | (8,784 | ) | |||||||||||||
|
Net increase (decrease) in cash and cash equivalents
|
23,584 | (47,197 | ) | 17,059 | 177,350 | (172,669 | ) | (27,171 | ) | |||||||||||||||
|
Cash and cash equivalents, Beginning of year
|
140,953 | 162,314 | 102,263 | 121,255 | 299,672 | 47,156 | ||||||||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(2,223 | ) | (12,854 | ) | 1,933 | 1,067 | 2,939 | 463 | ||||||||||||||||
|
Cash and cash equivalents, end of year
|
162,314 | 102,263 | 121,255 | 299,672 | 129,942 | 20,448 | ||||||||||||||||||
|
Payments due by September 30,
|
||||||||||||||||||||||||||||
|
Within
|
||||||||||||||||||||||||||||
|
Total
|
2011
|
2012
|
2013
|
2014
|
2015
|
Thereafter
|
||||||||||||||||||||||
|
RMB000
|
RMB000
|
RMB000
|
RMB000
|
RMB000
|
RMB000
|
RMB000
|
||||||||||||||||||||||
|
Operating Lease Obligations
|
10,411 | 2,626 | 1,238 | 936 | 1,034 | 901 | 3,676 | |||||||||||||||||||||
|
Capital Commitments (1)
|
21,092 | 21,092 | - | - | - | - | - | |||||||||||||||||||||
|
Short-Term Debt Obligations (2)
|
20,000 | 20,000 | - | - | - | - | - | |||||||||||||||||||||
|
Total
|
51,503 | 43,718 | 1,238 | 936 | 1,034 | 901 | 3,676 | |||||||||||||||||||||
|
|
(1)
|
Includes capital commitments for purchase of plant, building construction, equipment, land use rights and technology use rights.
|
|
|
(2)
|
Represents short term loans from Agricultural Bank of China Linze Branch.
|
|
Name
|
Age
|
Position
|
||
|
Gengchen Han
(1)
|
56
|
Chairman of the Board, President and Chief Executive Officer
|
||
|
Yasheng Yang
|
49
|
Vice Chairman of the Board
|
||
|
Liang Yuan
(2)
|
54
|
Director
|
||
|
Bailiang Zhang
|
70
|
Independent Director
|
||
|
James Kang
|
52
|
Independent Director
|
||
|
Min Tang
|
58
|
Independent Director
|
||
|
Yingqi Xia
|
58
|
Independent Director
|
||
|
Michael W. Trimble
|
54
|
Independent Director
|
||
|
Remo Richli
(3)
|
48
|
Independent Director
|
||
|
Larry Kenneth Cordell
(4)
|
54
|
Independent Director
|
||
|
Irving Kau
(5)
|
37
|
Interim Chief Financial Officer
|
|
1.
|
Dr. Gengchen Han was appointed as Chief Executive Officer, effective August 1, 2011.
|
|
2.
|
Liang Yuan resigned his position as Chief Executive Officer, effective August 1, 2011.
|
|
3.
|
Remo Richli will remain on the Board of Directors as the Audit Committee chair with the intention of resigning after the filing of the 20-F for FY2011.
|
|
4.
|
Larry Kenneth Cordell was appointed as Independent Director, effective January 1, 2012. He will succeed Remo Richli and become the Audit Committee Chair upon the resignation of Remo Richli.
|
|
5.
|
Irving Kau informed company of his decision to leave his position as Acting Chief Financial Officer as announced on July 15
th
, 2011. He subsequently remained on to assist and transition the company until January 1, 2012. James Chen was appointed Chief Financial Officer effective January 1, 2012.
|
|
Name
|
Ordinary
Shares
Underlying
Outstanding
Option
|
Exercise
Price
|
Grant Date
|
Expiration Date
|
|||||||
|
Gengchen Han
|
34,500 | $ | 4.00/Share |
November 8, 2005
|
November 8, 2010
|
||||||
| 20,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
|||||||
| 20,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Liang Yuan
|
13,800 | $ | 4.00/Share |
November 8, 2005
|
November 8, 2010
|
||||||
| 20,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
|||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Yasheng Yang
|
27,600 | $ | 4.00/Share |
November 8, 2005
|
November 8, 2010
|
||||||
| 5,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
|||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 3, 2016
|
|||||||
|
Remo Richli
|
15,000 | $ | 5.30/Share |
March 28, 2008
|
March 27, 2013
|
||||||
| 5,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
|||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Bailiang Zhang
|
10,000 | $ | 5.30/Share |
March 28, 2008
|
March 27, 2013
|
||||||
| 5,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
|||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Michael Trimble
|
25,000 | $ | 5.30/Share |
March 28, 2008
|
March 27, 2013
|
||||||
| 5,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
|||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Min Tang
|
10,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Yingqi Xia
|
5,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Y. James Kang
|
5,000 | $ | 12.23/Share |
January 4, 2010
|
January 3, 2015
|
||||||
| 5,000 | $ | 10.84/Share |
January 3, 2011
|
January 2, 2016
|
|||||||
|
Steven Urbach
|
6,900 | $ | 4.00/Share |
November 8, 2010
|
November 8, 2010
|
||||||
|
|
¨
|
annually reviewing and reassessing the adequacy of the Audit Committee’s formal charter;
|
|
|
¨
|
reviewing our annual audited financial statements with our management and our independent auditors and the adequacy of our internal accounting controls;
|
|
|
¨
|
reviewing analyses prepared by management and independent auditors concerning significant financial reporting issues and judgments made in connection with the preparation of our financial statements;
|
|
|
¨
|
the engagement of the independent auditor;
|
|
|
¨
|
reviewing the independence of the independent auditors;
|
|
|
¨
|
reviewing our auditing and accounting principles and practices with the independent auditors and reviewing major changes to our auditing and accounting principles and practices as suggested by the independent auditor or our management;
|
|
|
¨
|
the appointment of the independent auditor;
|
|
|
¨
|
approving professional services provided by the independent auditors, including the range of audit and non-audit fees; and
|
|
|
¨
|
reviewing all related party transactions on an ongoing basis for potential conflicts of interest.
|
|
|
¨
|
reviewing and making recommendations to our board of directors regarding our compensation policies and forms of compensation provided to our directors, officers and other senior employees;
|
|
|
¨
|
reviewing and determining performance-based awards and compensation for our officers and other employees;
|
|
|
¨
|
reviewing and determining share-based compensation (including the 2005 and 2009 Performance Equity Plan) for our directors, officers, employees and consultants;
|
|
|
¨
|
administering our equity incentive plans (including the 2005 and 2009 Performance Equity Plan) in accordance with the terms thereof; and
|
|
|
¨
|
such other matters that are specifically delegated to the Compensation Committee by our board of directors from time to time.
|
|
|
¨
|
actively seeking and evaluating qualified individuals to become new directors as needed;
|
|
|
¨
|
reviewing current directors’ suitability when their terms expire or one has a significant change in status;
|
|
|
¨
|
making recommendations with respect to succession planning for the co-chief executive officer and other officers; and
|
|
|
¨
|
such other matters that are specifically delegated to the Nominating Committee by our board of directors from time to time.
|
|
Areas of Operations
|
Number of
Employees
|
Percentage of
Total
|
||||||
|
Research and Development
|
125 | 14.6 | % | |||||
|
Sales and Marketing
|
230 | 26.9 | % | |||||
|
Production
|
271 | 31.6 | % | |||||
|
Quality Control
|
40 | 4.7 | % | |||||
|
Others
|
190 | 22.2 | % | |||||
|
Total
|
856 | 100.0 | % | |||||
|
|
¨
|
each of our directors and executive officers who beneficially own our ordinary shares; and
|
|
Shares Beneficially Owned
(
*
)
|
||||||||
|
Number
|
Percentage of
Total
|
|||||||
|
Directors and Executive Officers:
|
||||||||
|
Gengchen Han
Chairman of the Board, Chief Executive Officer
(1) (2)
|
3,653,500 | 15.7 | % | |||||
|
Liang Yuan
Director
(1) (3)
|
3,336,400 | 14.3 | % | |||||
|
Yasheng Yang
Vice Chairman of the Board and Director
(1) (4)
|
1,136,980 | 4.8 | % | |||||
|
Michael W. Trimble
Director
(5)
|
9,332 | 0.03 | % | |||||
|
Principal Shareholders:
|
||||||||
|
Fidelity Investments (FMR, Inc.)
|
3,100,590 | 13.27 | % | |||||
|
Guggenheim Capital and Fund
|
721,827 | 3.09 | % | |||||
|
Prescott Group Capital Management
|
666,778 | 2.85 | % | |||||
|
|
(1)
|
Unless otherwise indicated, the business address of each of the individuals is c/o 21 Shengmingyuan Road, Changping District, Beijing PRC 102206. See Item 6B. “Directors, Senior Management, and Employees – Compensation” for discussion of option included in the table granted under the 2005 and 2009 Performance Equity Plan.
|
|
|
(2)
|
The shares reported in the above table are held by Dr. Han through a personal holding company, Sinodream Limited, a company formed under the laws of the British Virgin Islands of which he is the sole shareholder, officer and director. Therefore, Dr. Han will have voting and dispositive authority over all the shares. Excludes 54,500 shares that may be acquired under exercisable stock options.
|
|
|
(3)
|
The shares reported in the above table are held by Mr. Yuan through a personal holding company, Bonasmart Limited, a company formed under the laws of the British Virgin Islands of which he is the sole shareholder, officer and director. Therefore, Mr. Yuan will have voting and dispositive authority over all the shares. Excludes 33,800 shares that may be acquired under exercisable stock options.
|
|
|
(4)
|
The shares reported in the above table are held by Mr. Yang through a personal holding company, Leekdon Limited, a company formed under the laws of the British Virgin Islands of which he is the sole shareholder, officer and director. Therefore, Mr. Yang will have voting and dispositive authority over all the shares. Excludes 32,600 shares that may be acquired under exercisable stock options.
|
|
|
(5)
|
The business address of Mr. Trimble is 6159 Brandywine Drive, Johnston, IA 50131. Excludes 30,000 shares that may be acquired under exercisable stock options.
|
|
|
The OTCBB
|
|
|
|||||||||||||||||
|
The OTCBB Price
|
Price per
|
The OTCBB
|
Nasdaq (2)
|
|||||||||||||||||
|
per Common Stock
|
Warrant
|
Price per Unit
|
Price per Share
|
|||||||||||||||||
|
High
|
Low
|
High
|
Low
|
High
|
Low
|
High
|
Low
|
|||||||||||||
|
Annual Market Prices
|
||||||||||||||||||||
|
Year 2005 (from November 8, 2005)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
13.8
|
8.75
|
||||||||||||
|
Transition period from January 1, 2006 through September 30, 2006)(1)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
18.35
|
9.31
|
||||||||||||
|
Year 2007 (until September 30, 2007)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
15.12
|
6.54
|
||||||||||||
|
Year 2008 (until September 30 2008)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
14.99
|
4.32
|
||||||||||||
|
Year 2009 (until September 30 2009)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
6.46
|
1.7
|
||||||||||||
|
Year 2010 (until September 30, 2010)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
15.02
|
4.40
|
||||||||||||
|
Year 2011(until September 30 2011)
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
11.31
|
2.33
|
||||||||||||
|
Quarterly Market Prices
|
||||||||||||||||||||
|
First Quarter 2008 ended December 31, 2007
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
14.99
|
5.23
|
||||||||||||
|
Second Quarter 2008 ended March 31, 2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
12.09
|
4.5
|
||||||||||||
|
Third Quarter 2008 ended June 30, 2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
7.65
|
5.1
|
||||||||||||
|
Fourth Quarter 2008 ended September 30, 2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
6.17
|
4.32
|
||||||||||||
|
First Quarter 2009 ended December 31, 2008
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
5.39
|
1.76
|
||||||||||||
|
Second Quarter 2009 ended March 31, 2009
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
3.52
|
1.7
|
||||||||||||
|
Third Quarter 2009 ended June 30, 2009
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
6.31
|
2.5
|
||||||||||||
|
Fourth Quarter 2009 ended September 30, 2009
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
6.46
|
3.75
|
||||||||||||
|
First Quarter 2010 ended December 31, 2009
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
14.57
|
4.40
|
||||||||||||
|
Second Quarter 2010 ended March 31, 2010
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
15.02
|
8.27
|
||||||||||||
|
Third Quarter 2010, ended June 30, 2010
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
10.83
|
6.63
|
||||||||||||
|
Fourth Quarter 2010 ended September 30, 2010
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
9.47
|
6.72
|
||||||||||||
|
First Quarter 2011 ended December 31, 2010
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
11.45
|
7.9
|
||||||||||||
|
Second Quarter 2011 ended March 31, 2011
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
11.31
|
7.7
|
||||||||||||
|
Third Quarter 2011, ended June 30, 2011
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
8
|
3.69
|
||||||||||||
|
Fourth Quarter 2011 ended September 30, 2011
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
4.95
|
2.33
|
||||||||||||
|
Monthly Market Prices
|
||||||||||||||||||||
|
Jul-11
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
4.95
|
4.1
|
||||||||||||
|
Aug-11
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
4.24
|
2.67
|
||||||||||||
|
Sep-11
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
2.86
|
2.33
|
||||||||||||
|
Oct-11
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
2.85
|
2.2
|
||||||||||||
|
Nov-11
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
3.05
|
2.42
|
||||||||||||
|
Dec-11
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
2.65
|
2.47
|
||||||||||||
|
|
¨
|
dealers in securities or currencies;
|
|
|
¨
|
traders in securities that elect to use a mark-to-market method of accounting for securities holdings;
|
|
|
¨
|
banks or other financial institutions;
|
|
|
¨
|
insurance companies;
|
|
|
¨
|
tax-exempt organizations;
|
|
|
¨
|
partnerships and other entities treated as partnerships for U.S. federal income tax purposes or persons holding ordinary shares through any such entities;
|
|
|
¨
|
persons that hold ordinary shares as part of a hedge, straddle, constructive sale, conversion transaction or other integrated investment;
|
|
|
¨
|
U.S. Holders (as defined below) whose functional currency for tax purposes is not the U.S. dollar;
|
|
|
¨
|
persons liable for alternative minimum tax; or
|
|
|
¨
|
persons who actually or constructively own 10% or more of the total combined voting power of all classes of our shares (including ordinary shares) entitled to vote.
|
|
|
¨
|
a citizen or resident of the United States for U.S. federal income tax purposes;
|
|
|
¨
|
a corporation, or other entity taxable as a corporation, that was created or organized in or under the laws of the United States or any political subdivision thereof;
|
|
|
¨
|
an estate the income of which is subject to U.S. federal income tax regardless of its source; or
|
|
|
¨
|
a trust if (a) a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (b) the trust has a valid election in effect to be treated as a U.S. person.
|
|
|
¨
|
that gain is effectively connected with the conduct of a U.S. trade or business and, if an applicable income tax treaty so requires as a condition for you to be subject to U.S. federal income tax with respect to income from your ordinary shares, such gain is attributable to a permanent establishment that you maintain in the United States; or
|
|
|
¨
|
you are a nonresident alien individual and are present in the United States for at least 183 days in the taxable year of the sale or other disposition and either (1) your gain is attributable to an office or other fixed place of business that you maintain in the United States or (2) you have a tax home in the United States.
|
|
Exhibit
|
||
|
Number
|
Description
|
|
|
1.1
|
CEO Certification Pursuant to Rule 13a-14(a) (17 CFR 240.13a-14(a)) (17 CFR 240.13a-14(a)) or Rule 15d-1(a) (17 CFR 240.15d-14(a))
|
|
|
1.2
|
CFO Certification Pursuant to Rule 13a-14(a) (17 CFR 240.13a-14(a)) or Rule 15d-1(a) (17 CFR 240.15d-14(a))
|
|
|
1.3
|
CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
1.4
|
CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
1.5
|
Consent of BDO China Shu Lun Pan Certified Public Accountants LLP to incorporation of its report on the Registrant's consolidated financial statements into Registrant's Registration Statements on Form S-8 and Form S-3
|
|
|
1.6
|
Consent of BDO Limited to incorporation of its report on the Registrant's consolidated financial statements into Registrant's Registration Statements on Form S-8 and Form S-3
|
|
Date: ____, 2012
|
ORIGIN AGRITECH LIMITED
|
|
|
/s/Gengchen Han
|
||
|
Name:
|
Gengchen Han
|
|
|
Title:
|
Chief Executive Officer
|
|
|
CONTENTS
|
PAGE
|
|
|
REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS
|
F–1
|
|
|
CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2010 AND 2011
|
F–3
|
|
|
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME FOR THE YEARS ENDED SEPTEMBER 30, 2009, 2010 AND 2011
|
F–4
|
|
|
CONSOLIDATED STATEMENTS OF EQUITY FOR THE YEARS ENDED SEPTEMBER 30, 2009, 2010 AND 2011
|
F–5
|
|
|
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2009, 2010 AND 2011
|
F–6
|
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
|
F–8
|
|
September 30,
|
||||||||||||
|
2010
|
2011
|
2011
|
||||||||||
|
RMB
|
RMB
|
USD
|
||||||||||
|
ASSETS
|
||||||||||||
|
Current Assets
|
||||||||||||
|
Cash and cash equivalents
|
299,672 | 129,942 | 20,448 | |||||||||
|
Accounts receivable, less allowance for doubtful amounts of RMB842 and RMB2,714 as of September 30, 2010 and 2011, respectively (note 4)
|
10,048 | 6,616 | 1,041 | |||||||||
|
Due from related parties (note 3)
|
5,107 | 5,183 | 816 | |||||||||
|
Advances to suppliers (note 5)
|
3,986 | 12,418 | 1,954 | |||||||||
|
Advances to growers
|
40,691 | 78,623 | 12,372 | |||||||||
|
Inventories (note 6)
|
283,174 | 210,826 | 33,175 | |||||||||
|
Income tax recoverable (note 19)
|
2,745 | 2,155 | 339 | |||||||||
|
Other current assets (note 7)
|
18,838 | 65,055 | 10,237 | |||||||||
|
Total current assets
|
664,261 | 510,818 | 80,382 | |||||||||
|
Land use rights, net (note 8)
|
20,907 | 33,094 | 5,208 | |||||||||
|
Plant and equipment, net (note 9)
|
161,681 | 190,094 | 29,913 | |||||||||
|
Equity investments (note 10)
|
22,505 | 20,503 | 3,226 | |||||||||
|
Goodwill (note 2)
|
16,665 | 11,973 | 1,884 | |||||||||
|
Acquired intangible assets, net (note 11)
|
35,344 | 29,232 | 4,600 | |||||||||
|
Deferred income tax assets (note 19)
|
9,766 | 3,028 | 476 | |||||||||
|
Other assets (note 12)
|
3,882 | 19,640 | 3,091 | |||||||||
|
Total assets
|
935,011 | 818,382 | 128,780 | |||||||||
|
LIABILITIES AND EQUITY
|
||||||||||||
|
Current liabilities
|
||||||||||||
|
Short-term borrowings (note 13)
|
85,900 | 20,000 | 3,147 | |||||||||
|
Accounts payable
|
8,960 | 5,740 | 903 | |||||||||
|
Due to growers
|
42,186 | 7,947 | 1,251 | |||||||||
|
Due to related parties (note 3)
|
7,926 | 1,728 | 272 | |||||||||
|
Advances from customers
|
348,797 | 397,933 | 62,618 | |||||||||
|
Deferred revenues
|
23,111 | 19,812 | 3,118 | |||||||||
|
Income tax payable (note 19; note 22)
|
44,075 | 39,060 | 6,146 | |||||||||
|
Other payables and accrued expenses (note 15)
|
35,656 | 40,351 | 6,350 | |||||||||
|
Total current liabilities
|
596,611 | 532,571 | 83,805 | |||||||||
|
Other long-term liabilities (note 16)
|
9,426 | - | - | |||||||||
|
Total liabilities
|
606,037 | 532,571 | 83,805 | |||||||||
|
Commitments and contingencies (note 22)
|
||||||||||||
|
Shareholders’ equity:
|
||||||||||||
|
Preferred stock (no par value; 1,000,000 shares authorized, none issued)
|
- | - | - | |||||||||
|
Common stock (no par value; 60,000,000 shares authorized, 23,292,412 and 23,382,812 shares issued and outstanding as of September 30, 2010 and 2011 respectively)
|
- | |||||||||||
|
Additional paid-in capital
|
387,052 | 394,344 | 62,054 | |||||||||
|
Retained earnings (deficit)
|
(76,454 | ) | (99,533 | ) | (15,662 | ) | ||||||
|
Treasury stock at cost (498,851 shares) (note 18)
|
(29,377 | ) | (29,377 | ) | (4,623 | ) | ||||||
|
Accumulated other comprehensive loss
|
(9,336 | ) | (6,397 | ) | (1,007 | ) | ||||||
|
Total Origin Agritech Limited shareholders’ equity
|
271,885 | 259,037 | 40,762 | |||||||||
|
Non-controlling interests
|
57,089 | 26,774 | 4,213 | |||||||||
|
Total equity
|
328,974 | 285,811 | 44,975 | |||||||||
|
Total liabilities and equity
|
935,011 | 818,382 | 128,780 | |||||||||
|
Year ended September 30,
|
||||||||||||||||
|
2009
|
2010
|
2011
|
2011
|
|||||||||||||
|
RMB
|
RMB
|
RMB
|
USD
|
|||||||||||||
|
Revenues
|
592,492 | 584,860 | 567,434 | 89,291 | ||||||||||||
|
Cost of revenues
|
(392,842 | ) | (353,587 | ) | (371,591 | ) | (58,473 | ) | ||||||||
|
Gross profit
|
199,650 | 231,273 | 195,843 | 30,818 | ||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Selling and marketing
|
(55,648 | ) | (52,227 | ) | (56,831 | ) | (8,943 | ) | ||||||||
|
General and administrative
|
(64,833 | ) | (78,708 | ) | (86,748 | ) | (13,651 | ) | ||||||||
|
Research and development
|
(33,473 | ) | (38,356 | ) | (44,771 | ) | (7,045 | ) | ||||||||
|
Other income, net
|
1,991 | 2,340 | 5,120 | 806 | ||||||||||||
|
Total operating expenses, net
|
(151,963 | ) | (166,951 | ) | (183,230 | ) | (28,833 | ) | ||||||||
|
Income from operations
|
47,687 | 64,322 | 12,613 | 1,985 | ||||||||||||
|
Interest expense
|
(16,784 | ) | (8,539 | ) | (1,469 | ) | (231 | ) | ||||||||
|
Share of net income of equity investments
|
4,669 | 9,370 | 1,616 | 254 | ||||||||||||
|
Gain on disposal of an equity investment
|
- | 8,883 | - | - | ||||||||||||
|
Loss on liquidation of a subsidiary (note 1)
|
- | - | (13,582 | ) | (2,137 | ) | ||||||||||
|
Interest income
|
2,036 | 1,634 | 1,771 | 279 | ||||||||||||
|
Loss on repurchase of convertible notes (note 14)
|
(51,101 | ) | - | - | - | |||||||||||
|
Changes in the fair value of embedded derivatives
|
3,300 | - | - | - | ||||||||||||
|
Income before income taxes
|
(10,193 | ) | 75,670 | 949 | 150 | |||||||||||
|
Income tax expense (note 19)
|
||||||||||||||||
|
Current
|
(580 | ) | (4,046 | ) | (6,991 | ) | (1,100 | ) | ||||||||
|
Deferred
|
(11,152 | ) | (5,273 | ) | (6,739 | ) | (1,060 | ) | ||||||||
|
Income tax expense
|
(11,732 | ) | (9,319 | ) | (13,730 | ) | (2,160 | ) | ||||||||
|
Net income (loss)
|
(21,925 | ) | 66,351 | (12,781 | ) | (2,010 | ) | |||||||||
|
Less: Net income attributable to non-controlling interests
|
18,892 | 17,298 | 10,298 | 1,620 | ||||||||||||
|
Net income (loss) attributable to Origin Agritech Limited
|
(40,817 | ) | 49,053 | (23,079 | ) | (3,630 | ) | |||||||||
|
Other comprehensive income (loss)
|
||||||||||||||||
|
Net income (loss)
|
(21,925 | ) | 66,351 | (12,781 | ) | (2,010 | ) | |||||||||
|
Foreign currency translation difference
|
366 | 1,067 | 2,939 | 462 | ||||||||||||
|
Comprehensive income (loss)
|
(21,559 | ) | 67,418 | (9,842 | ) | (1,548 | ) | |||||||||
|
Less: Comprehensive income attributable to non-controlling interests
|
18,892 | 17,298 | 10,298 | 1,620 | ||||||||||||
|
Comprehensive income (loss) attributable to Origin Agritech Limited
|
(40,451 | ) | 50,120 | (20,140 | ) | (3,168 | ) | |||||||||
|
Net income (loss) attributable to Origin Agritech Limited per share – basic (note 20)
|
RMB | (1.77 | ) | RMB | 2.12 | RMB | (1.00 | ) | USD | (0.16 | ) | |||||
|
Net income (loss) attributable to Origin Agritech Limited per share – diluted (note 20)
|
RMB | (1.77 | ) | RMB | 2.10 | RMB | (1.00 | ) | USD | (0.16 | ) | |||||
|
Shares used in calculating basic net income (loss) per share
|
23,013,692 | 23,189,464 | 23,072,895 | 23,072,895 | ||||||||||||
|
Shares used in calculating diluted net income (loss) per share
|
23,013,692 | 23,337,265 | 23,072,895 | 23,072,895 | ||||||||||||
|
Equity attributable to Origin Agritech Limited
|
||||||||||||||||||||||||||||||||
|
Accumulated
|
||||||||||||||||||||||||||||||||
|
Additional
|
Retained
|
Other
|
Non-
|
|||||||||||||||||||||||||||||
|
Common stock
|
Paid-in
|
Earnings
|
Comprehensive
|
Treasury
|
controlling
|
Total
|
||||||||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
(Deficit)
|
Income (Loss)
|
Stock
|
interest
|
Equity
|
|||||||||||||||||||||||||
|
RMB
|
RMB
|
RMB
|
RMB
|
RMB
|
RMB
|
RMB
|
||||||||||||||||||||||||||
|
Balance as of October 1, 2008
|
23,013,692 | - | 388,860 | (84,690 | ) | (10,769 | ) | (29,377 | ) | 39,224 | 303,248 | |||||||||||||||||||||
|
Net income (loss) for the year
|
- | - | - | (40,817 | ) | - | - | 18,892 | (21,925 | ) | ||||||||||||||||||||||
|
Share-based compensation expense
|
- | - | 2,760 | - | - | - | - | 2,760 | ||||||||||||||||||||||||
|
Dividend paid to non-controlling interests
|
- | - | - | - | - | - | (6,727 | ) | (6,727 | ) | ||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | - | 366 | - | - | 366 | ||||||||||||||||||||||||
|
Balance as of September 30, 2009 and October 1, 2010
|
23,013,692 | - | 391,620 | (125,507 | ) | (10,403 | ) | (29,377 | ) | 51,389 | 277,722 | |||||||||||||||||||||
|
Net income for the year
|
- | - | - | 49,053 | - | - | 17,298 | 66,351 | ||||||||||||||||||||||||
|
Issuance of common stock upon exercise of share options
|
278,720 | - | 6,535 | - | - | - | - | 6,535 | ||||||||||||||||||||||||
|
Acquisition of additional equity interest in a subsidiary from non-controlling interests
|
- | - | (15,971 | ) | - | - | - | (8,229 | ) | (24,200 | ) | |||||||||||||||||||||
|
Share-based compensation expense
|
- | - | 4,868 | - | - | - | - | 4,868 | ||||||||||||||||||||||||
|
Acquisition of a subsidiary
|
- | - | - | - | - | - | 3,538 | 3,538 | ||||||||||||||||||||||||
|
Dividend paid to non-controlling interests
|
- | - | - | - | - | - | (6,907 | ) | (6,907 | ) | ||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | - | 1,067 | - | - | 1,067 | ||||||||||||||||||||||||
|
Balance as of September 30, 2010 and October 1, 2010
|
23,292,412 | - | 387,052 | (76,454 | ) | (9,336 | ) | (29,377 | ) | 57,089 | 328,974 | |||||||||||||||||||||
|
Net income (loss) for the year
|
- | - | - | (23,079 | ) | - | - | 10,298 | (12,781 | ) | ||||||||||||||||||||||
|
Issuance of common stock upon exercise of share options
|
90,400 | - | 2,654 | - | - | - | - | 2,654 | ||||||||||||||||||||||||
|
Share-based compensation expense
|
- | - | 4,638 | - | - | - | - | 4,638 | ||||||||||||||||||||||||
|
New subsidiary established
|
- | - | - | - | - | - | 19,600 | 19,600 | ||||||||||||||||||||||||
|
Liquidation of a subsidiary
|
- | - | - | - | - | - | (48,123 | ) | (48,123 | ) | ||||||||||||||||||||||
|
Dividend paid to non-controlling interests
|
- | - | - | - | - | - | (12,090 | ) | (12,090 | ) | ||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | - | 2,939 | - | 2,939 | |||||||||||||||||||||||||
|
Balance as of September 30, 2011
|
23,382,812 | - | 394,344 | (99,533 | ) | (6,397 | ) | (29,377 | ) | 26,774 | 285,811 | |||||||||||||||||||||
|
In US$ @ 6.3549
|
- | 62,054 | (15,662 | ) | (1,007 | ) | (4,623 | ) | 4,213 | 44,975 | ||||||||||||||||||||||
|
Year ended September 30,
|
||||||||||||||||
|
2009
|
2010
|
2011
|
2011
|
|||||||||||||
|
RMB
|
RMB
|
RMB
|
USD
|
|||||||||||||
|
Operating activities:
|
||||||||||||||||
|
Net income (loss)
|
(40,817 | ) | 49,053 | (23,079 | ) | (3,630 | ) | |||||||||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||||||||||
|
Depreciation and amortization
|
21,266 | 21,712 | 23,307 | 3,668 | ||||||||||||
|
Loss (gain) on disposal of plant and equipment
|
457 | (26 | ) | 6,252 | 984 | |||||||||||
|
Gain on disposal of an equity investment
|
- | (8,883 | ) | (1 | ) | - | ||||||||||
|
Loss on liquidation of a subsidiary
|
- | - | 13,583 | 2,137 | ||||||||||||
|
Change in the fair value of embedded derivatives
|
(3,300 | ) | - | - | - | |||||||||||
|
Impairment on receivables
|
26 | - | 1,872 | 294 | ||||||||||||
|
Inventory write down
|
7,395 | 14,971 | 12,978 | 2,042 | ||||||||||||
|
Loss on repurchase of convertible note
|
51,101 | - | - | - | ||||||||||||
|
Interest expense and amortization of discount on convertible notes
|
3,799 | - | - | - | ||||||||||||
|
Deferred income tax assets
|
11,152 | 5,274 | 6,739 | 1,060 | ||||||||||||
|
Non-controlling interests
|
18,892 | 17,298 | 10,298 | 1,620 | ||||||||||||
|
Share-based compensation expense
|
2,760 | 4,868 | 4,638 | 730 | ||||||||||||
|
Share of net income of equity investments
|
(4,669 | ) | (9,370 | ) | (1,616 | ) | (254 | ) | ||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||||||
|
Accounts receivable, net
|
(1,006 | ) | (4,356 | ) | 1,560 | 245 | ||||||||||
|
Due from related parties
|
3,538 | 1,897 | (76 | ) | (12 | ) | ||||||||||
|
Advances to growers
|
20,807 | (16,010 | ) | (37,932 | ) | (5,969 | ) | |||||||||
|
Advances to suppliers
|
- | 2,940 | (8,432 | ) | (1,327 | ) | ||||||||||
|
Inventories
|
38,569 | 45,783 | 15,175 | 2,388 | ||||||||||||
|
Income tax recoverable
|
(28 | ) | (1,020 | ) | 590 | 93 | ||||||||||
|
Other current assets
|
2,444 | 98 | 4 | 1 | ||||||||||||
|
Other assets
|
10,182 | 3,193 | (3,010 | ) | (474 | ) | ||||||||||
|
Accounts payable
|
6,014 | (5,137 | ) | (3,220 | ) | (507 | ) | |||||||||
|
Due to growers
|
(4,414 | ) | 32,567 | (34,239 | ) | (5,388 | ) | |||||||||
|
Due to related parties
|
16,856 | (7,773 | ) | 984 | 155 | |||||||||||
|
Advances from customers
|
81,159 | 128,834 | 49,136 | 7,732 | ||||||||||||
|
Deferred revenues
|
(16,568 | ) | 4,831 | (3,299 | ) | (519 | ) | |||||||||
|
Income tax payable
|
602 | 4,414 | 4,113 | 647 | ||||||||||||
|
Other long-term liabilities
|
(3,658 | ) | 9,426 | (7,003 | ) | (1,102 | ) | |||||||||
|
Other payables and accrued expenses
|
(13,676 | ) | 4,020 | 8,135 | 1,280 | |||||||||||
|
Net cash provided by operating activities
|
208,883 | 298,604 | 37,457 | 5,894 | ||||||||||||
|
Year ended September 30,
|
||||||||||||||||
|
2009
|
2010
|
2011
|
2011
|
|||||||||||||
|
RMB
|
RMB
|
RMB
|
USD
|
|||||||||||||
|
Investing activities:
|
||||||||||||||||
|
Dividends received
|
4,600 | 1,200 | 2,467 | 388 | ||||||||||||
|
Purchase of plant and equipment
|
(18,804 | ) | (15,839 | ) | (56,332 | ) | (8,864 | ) | ||||||||
|
Liquidation of a subsidiary
|
- | - | (67,980 | ) | (10,697 | ) | ||||||||||
|
Proceeds from disposal of an equity investment
|
- | 50,000 | - | - | ||||||||||||
|
Additional capital injection to an equity investment
|
- | - | (600 | ) | (95 | ) | ||||||||||
|
Proceeds from disposal of plant and equipment
|
1,395 | 247 | - | - | ||||||||||||
|
Deposits for purchase of acquired technology and land use rights
|
(2,650 | ) | (39 | ) | (1,280 | ) | (201 | ) | ||||||||
|
Deposits for purchase of plant and equipment
|
(332 | ) | (3,044 | ) | (11,468 | ) | (1,805 | ) | ||||||||
|
Business acquisition, net of cash acquired
|
- | (10,540 | ) | - | - | |||||||||||
|
Purchase of intangible assets
|
(100 | ) | (6,880 | ) | (19,197 | ) | (3,021 | ) | ||||||||
|
Net cash provided by/(used in) investing activities
|
(15,891 | ) | 15,105 | (154,390 | ) | (24,295 | ) | |||||||||
|
Financing activities:
|
||||||||||||||||
|
Restricted bank deposits
|
(500 | ) | 500 | - | - | |||||||||||
|
Proceeds from short-term borrowings
|
134,850 | 191,900 | 20,000 | 3,147 | ||||||||||||
|
Repayment of short-term borrowings
|
(219,440 | ) | (186,290 | ) | (85,900 | ) | (13,517 | ) | ||||||||
|
Repayment of third party loans
|
(4,560 | ) | - | - | - | |||||||||||
|
Repurchase of convertible notes
|
(68,290 | ) | (117,896 | ) | - | - | ||||||||||
|
Acquisition of additional equity interest from non-controlling shareholders
|
- | (24,200 | ) | - | - | |||||||||||
|
Capital injection from a non-controlling shareholder
|
- | - | 19,600 | 3,084 | ||||||||||||
|
Dividends paid to non-controlling shareholders
|
(17,993 | ) | (6,908 | ) | (12,090 | ) | (1,902 | ) | ||||||||
|
Proceeds from exercise of share options
|
- | 6,535 | 2,654 | 418 | ||||||||||||
|
Net cash used in financing activities
|
(175,933 | ) | (136,359 | ) | (55,736 | ) | (8,770 | ) | ||||||||
|
Net increase (decrease) in cash and cash equivalents
|
17,059 | 177,350 | (172,669 | ) | (27,171 | ) | ||||||||||
|
Cash and cash equivalents, beginning of year
|
102,263 | 121,255 | 299,672 | 47,156 | ||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
1,933 | 1,067 | 2,939 | 463 | ||||||||||||
|
Cash and cash equivalents, end of year
|
121,255 | 299,672 | 129,942 | 20,448 | ||||||||||||
|
Supplemental disclosures of cash flow information:
|
||||||||||||||||
|
Income taxes paid
|
6 | 652 | 6,990 | 1,100 | ||||||||||||
|
Interest paid
|
11,574 | 8,539 | 1,469 | 231 | ||||||||||||
|
Supplemental disclosure of non-cash investing activities:
|
||||||||||||||||
|
Other current assets to be received from liquidation of a subsidiary
|
- | - | 45,236 | 7,118 | ||||||||||||
|
1.
|
ORGANIZATION AND PRINCIPAL ACTIVITIES
|
|
Date of
|
Place of
|
Percentage
|
||||||||
|
Incorporation
|
Incorporation
|
of |
Principal
|
|||||||
|
Name
|
or Establishment
|
or Establishment
|
Ownership
|
Activity
|
||||||
|
Subsidiaries
:
|
||||||||||
|
State Harvest Holdings Limited (“State Harvest”)
|
October 6, 2004
|
British Virgin Islands
|
100 | % |
Investment Holding
|
|||||
|
Beijing Origin State Harvest Biotechnology Limited (“BioTech”)
|
December 1, 2004
|
People’s Republic of China (“PRC”)
|
100 | % |
Hybrid seed Technology development
|
|||||
|
Shandong Kunfeng Biochemical Limited (“Kunfeng”)
|
June 14, 2006
|
PRC
|
80 | % |
Agricultural chemical producer
|
|||||
|
Variable interest entity
:
|
||||||||||
|
Beijing Origin Seed Limited (note (i)) (“Beijing Origin”)
|
December 26, 1997
|
PRC
|
- |
Hybrid crop seed development, production and distribution
|
||||||
|
Subsidiaries held by Beijing Origin:
|
||||||||||
|
Henan Origin Cotton Technology Development Limited (note (i)) (“Henan Cotton”)
|
March 2, 2001
|
PRC
|
92.04 | % |
Hybrid crop seed development, production and distribution
|
|||||
|
Changchun Origin Seed Technology Development Limited (note (i)) (“Changchun Origin”)
|
April 29, 2003
|
PRC
|
99 | % |
Hybrid crop seed development, production and distribution
|
|||||
|
Linze Origin Seed Limited (note (i))
|
November 18, 2008
|
PRC
|
100 | % |
Hybrid crop seed development, production and distribution
|
|||||
|
Xinjiang Originbo Seed Company Limited (“Xinjiang Origin”) (note (i))
|
July 13, 2011
|
PRC
|
51 | % |
Hybrid crop seed development, production and distribution
|
|||||
|
Denong Zhengcheng Seed Limited (“Denong”)
|
June 21, 2000
|
PRC
|
97.87 | % |
Hybrid seed development, production and distribution
|
|||||
|
|
Note (i):
|
Beijing Origin Seed Limited, Henan Origin Cotton Technology Development Limited, Changchun Origin Seed Technology Development Limited, Linze Origin Seed Limited and Xinjiang Originbo Seed Company Limited are collectively referred to as “Beijing Origin”.
|
|
|
Note (ii):
|
As of September 28, 2011, Jilin Changrong has substantially completed its liquidation procedures and then legally deregistered subsequently after the fiscal year end.
|
|
1.
|
ORGANIZATION AND PRINCIPAL ACTIVITIES - Continued
|
|
RMB
|
||||
|
Net assets acquired:
|
||||
|
Cash
|
163,517 | |||
|
Other current assets
|
6,201 | |||
|
Due to State Harvest Shareholders and their designee
|
(2,022 | ) | ||
|
Other payables and accrued expenses
|
(965 | ) | ||
| 166,731 | ||||
|
Less: Transaction costs paid in cash
|
(14,431 | ) | ||
|
Tax effect of the Share Exchange Transaction
|
(39,059 | ) | ||
| 113,241 | ||||
|
1.
|
ORGANIZATION AND PRINCIPAL ACTIVITIES - Continued
|
|
|
(1)
|
If Agritech receives at least US$40,000 in gross proceeds in additional financing as a result (i) of the call of the issued and outstanding public warrants assumed by Agritech at the closing; (ii) Agritech’s successful completion of a follow-on offering; or (iii) a private investment into Agritech by a strategic investor (“Financing Adjustment”), then Agritech will pay an additional US$15,000 to State Harvest Shareholders and their designee; or
|
|
|
(2)
|
If Origin generates net positive cash flow of US$2,000 or more on a consolidated basis (“Earnings Adjustment”), then State Harvest Shareholders and their designee will be entitled to receive 75% of the net positive cash flow up to a maximum of US$7,500 per fiscal year and US$15,000 in the aggregate.
|
|
|
If both an Earnings Adjustment and a Financing Adjustment occur, the maximum aggregate amount to be paid to State Harvest Shareholders from one or both adjustments is US$15,000.
|
|
After-tax profit
|
||||
|
US$
|
||||
|
Twelve months ended June 30,
|
||||
|
2006
|
11,000 | |||
|
2007
|
16,000 | |||
|
2008
|
21,000 | |||
|
2009
|
29,000 | |||
|
1.
|
ORGANIZATION AND PRINCIPAL ACTIVITIES - Continued
|
|
1.
|
ORGANIZATION AND PRINCIPAL ACTIVITIES - Continued
|
|
RMB
|
||||
|
Carrying amount of net assets in the books of Changrong at liquidation
|
105,251 | |||
|
Attributable goodwill
|
4,692 | |||
| 109,943 | ||||
|
Less:Net assets at the date of liquidation attributable to non-controlling interests
|
48,123 | |||
|
Net assets at the date of liquidation attributable to Origin Agritech Limited
|
61,820 | |||
|
Satisfied by:
|
||||
|
Cash
|
3,001 | |||
|
Other current assets
|
45,236 | |||
| 48,237 | ||||
|
Loss on liquidation of a subsidiary
|
13,583 | |||
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
Plant and building
|
20-40 years
|
|
Machinery and equipment
|
10-15 years
|
|
Furniture and office equipment
|
5-8 years
|
|
Motor vehicles
|
5-10 years
|
|
Leasehold improvements
|
Shorter of the useful lives or the lease term
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Balance at beginning of year
|
16,665 | 16,665 | 16,665 | |||||||||
|
Additions
|
- | - | - | |||||||||
|
Written off
|
- | - | (4,692 | ) | ||||||||
| 16,665 | 16,665 | 11,973 | ||||||||||
|
Technology rights for licensed seeds
|
3-20 years
|
|
Distribution network
|
6-14 years
|
|
Trademark
|
Indefinite
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
|
|
3.
|
RELATED PARTY BALANCES AND TRANSACTIONS
|
|
|
(1)
|
Related party relationships
|
|
Name of related parties
|
Relationship
|
|
|
Shenzhen Biocentury Transgene (China) Limited (“Biocentury”)
|
Being an equity investment of the Company which disposed on May 27, 2010 (note 10)
|
|
|
Jinong
|
Being an equity investment of the Company (note 10)
|
|
|
Liyu
|
Being an equity investment of the Company (note 10)
|
|
|
Henan Agriculture University
|
Being non-controlling interests of Beijing Origin
|
|
|
Xinjiang Jinbo Seed Limited
|
Being non-controlling interests of Xinjiang Origin
|
|
|
Mr. Zhai
|
Being non-controlling interests of Kunfeng
|
|
(2)
|
Due from related parties
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Jinong (note (i))
|
6 | 3,505 | ||||||
|
Henan Agriculture University
|
- | 24 | ||||||
|
Liyu
|
3,094 | - | ||||||
|
Non-controlling interests of Denong
|
7 | 7 | ||||||
|
Non-controlling interests of Changrong
|
2,000 | - | ||||||
|
Non-controlling interests of Xinjiang Origin
|
- | 1,447 | ||||||
|
Non-controlling interests of Kunfeng
|
- | 200 | ||||||
| 5,107 | 5,183 | |||||||
|
|
Note (i):
|
The balance as of September 30, 2011 represented the deposit paid to Jinong for purchasing of seeds.
|
|
3.
|
RELATED PARTY BALANCES AND TRANSACTIONS - Continued
|
|
|
(3)
|
Due to related parties
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Non-controlling interests of Denong (note (i))
|
113 | 113 | ||||||
|
Non-controlling interests of Beijing Origin
|
68 | - | ||||||
|
Companies controlled by the Company’s directors
|
1,461 | 1,385 | ||||||
|
Ex-shareholders of State Harvest
|
147 | 140 | ||||||
|
Jinong
|
6,137 | - | ||||||
|
Liyu
|
- | 90 | ||||||
| 7,926 | 1,728 | |||||||
|
|
Note (i):
|
This is the amount temporarily funded by non-controlling interests of Denong. The amount is payable on demand with interest free.
|
|
(4)
|
Transactions with related parties
|
|
(a)
|
Sales
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Jinong
|
- | - | 2,000 | |||||||||
|
(b)
|
Purchases
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Biocentury
|
116 | 116 | - | |||||||||
|
Liyu
|
- | 240 | 90 | |||||||||
|
Jinong
|
- | 6 | - | |||||||||
| 116 | 362 | 90 | ||||||||||
|
3.
|
RELATED PARTY BALANCES AND TRANSACTIONS – Continued
|
|
(4)
|
Transactions with related parties - Continued
|
|
|
(c)
|
Technology usage fees
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Liyu
|
5,752 | 5,471 | 5,953 | |||||||||
|
Henan Agriculture University
|
108 | 68 | - | |||||||||
|
Non-controlling interests of Denong
|
566 | 599 | 602 | |||||||||
|
Biocentury
|
300 | 306 | - | |||||||||
| 6,726 | 6,444 | 6,555 | ||||||||||
|
(d)
|
Sales of plant and equipment
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Non-controlling interests of Denong
|
8 | - | - | |||||||||
|
Jinong
|
640 | - | - | |||||||||
| 648 | - | - | ||||||||||
|
(e)
|
Purchases of plant and equipment
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Jinong
|
- | 150 | - | |||||||||
|
(f)
|
Interest income
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Non-controlling interests of Changrong
|
261 | - | - | |||||||||
|
3.
|
RELATED PARTY BALANCES AND TRANSACTIONS – Continued
|
|
|
(g)
|
Rental expense paid for plant and equipment
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Jinong
|
1,687 | 935 | 468 | |||||||||
|
(h)
|
Research & Development expenses
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Holding company of Jinong
|
5,000 | 5,000 | 5,000 | |||||||||
|
(i)
|
Dividend received
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Biocentury
|
3,400 | - | - | |||||||||
|
Liyu
|
1,200 | 1,200 | 2,467 | |||||||||
| 4,600 | 1,200 | 2,467 | ||||||||||
|
(j)
|
Dividend paid
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Jinong
|
4,020 | 5,025 | 10,050 | |||||||||
|
4.
|
ACCOUNTS RECEIVABLE
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Balance at beginning of year
|
816 | 842 | 842 | |||||||||
|
Additions
|
26 | - | 1,872 | |||||||||
|
Written off
|
- | - | - | |||||||||
| 842 | 842 | 2,714 | ||||||||||
|
5.
|
ADVANCES TO SUPPLIERS
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Purchases of materials
|
1,471 | 7,460 | ||||||
|
Prepayments for advertisement
|
10 | 280 | ||||||
|
Prepayments for transportation fee
|
518 | - | ||||||
|
Prepayments for operating lease
|
290 | 218 | ||||||
|
Prepayments for testing fee
|
106 | 284 | ||||||
|
Utility deposit
|
270 | 935 | ||||||
|
Deposits for research and development fee
|
566 | 1,301 | ||||||
|
Deposits for housing fund center
|
- | 323 | ||||||
|
Others
|
755 | 1,617 | ||||||
| 3,986 | 12,418 | |||||||
|
6.
|
INVENTORIES
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Work in progress and supplies
|
172,708 | 111,945 | ||||||
|
Finished goods
|
132,492 | 120,134 | ||||||
|
Provision
|
(22,026 | ) | (21,253 | ) | ||||
| 283,174 | 210,826 | |||||||
|
6.
|
INVENTORIES - Continued
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Balance at beginning of year
|
30,818 | 28,859 | 22,026 | |||||||||
|
Additions
|
7,395 | 14,971 | 12,978 | |||||||||
|
Write-off
|
(9,354 | ) | (21,804 | ) | (13,751 | ) | ||||||
| 28,859 | 22,026 | 21,253 | ||||||||||
|
7.
|
OTHER CURRENT ASSETS
|
|
September 30,
|
|||||||||
|
2010
|
2011
|
||||||||
|
RMB
|
RMB
|
||||||||
|
Advances to staff for business use
|
6,428 | 8,287 | |||||||
|
Refundable deposit for a cancelled project
|
441 | 241 | |||||||
|
Receivable from a private investor arising from a sale of equity investment
|
10,000 | - | |||||||
|
Receivable from liquidation of Changrong
|
- | 45,236 | |||||||
|
Receivable from liquidation of Changji
|
- | 1,751 | |||||||
|
Loan to a customer
|
Note (i)
|
- | 3,000 | ||||||
|
Deposits for rental
|
114 | 2,666 | |||||||
|
Deposits for research and development
|
- | 2,195 | |||||||
|
Others
|
1,855 | 1,679 | |||||||
| 18,838 | 65,055 | ||||||||
|
|
Note (i)
|
The balance represented the loan to one of the customers in Denong with the interest rate of 6.1% per annum. Fully repayment will be made in the end of February 2012 together with the interest by according to the loan agreement.
|
|
8.
|
LAND USE RIGHTS, NET
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Land use rights
|
23,880 | 36,569 | ||||||
|
Accumulated amortization
|
(2,973 | ) | (3,475 | ) | ||||
|
Land use rights, net
|
20,907 | 33,094 | ||||||
|
8.
|
LAND USE RIGHTS, NET - Continued
|
|
9.
|
PLANT AND EQUIPMENT, NET
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Plant and building
|
133,874 | 140,301 | ||||||
|
Machinery and equipment
|
41,677 | 52,972 | ||||||
|
Furniture and office equipment
|
12,309 | 11,466 | ||||||
|
Motor vehicles
|
20,082 | 18,338 | ||||||
|
Leasehold improvements
|
1,299 | 212 | ||||||
|
Total
|
209,241 | 223,289 | ||||||
|
Accumulated depreciation
|
(55,643 | ) | (61,438 | ) | ||||
|
Construction in progress
|
8,083 | 28,243 | ||||||
|
Plant and equipment, net
|
161,681 | 190,094 | ||||||
|
10.
|
EQUITY INVESTMENTS
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Equity method investment
|
22,505 | 20,503 | ||||||
|
10.
|
EQUITY INVESTMENTS- Continued
|
|
11.
|
ACQUIRED INTANGIBLE ASSETS, NET
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Technology rights for licensed seeds
|
74,265 | 74,723 | ||||||
|
Distribution network
|
6,975 | 6,739 | ||||||
|
Trademark and certificates
|
3,394 | 1,687 | ||||||
|
Others
|
4,530 | 4,763 | ||||||
| 89,164 | 87,912 | |||||||
|
Accumulated amortization
|
(49,506 | ) | (54,366 | ) | ||||
|
Impairment provision
|
(4,314 | ) | (4,314 | ) | ||||
|
Acquired intangible assets, net
|
35,344 | 29,232 | ||||||
|
11.
|
ACQUIRED INTANGIBLE ASSETS, NET - Continued
|
|
Year ending September 30,
|
RMB
|
|||
|
2012
|
5,619 | |||
|
2013
|
3,926 | |||
|
2014
|
3,097 | |||
|
2015
|
2,339 | |||
|
2016
|
1,789 | |||
|
Total
|
16,770 | |||
|
12.
|
OTHER ASSETS
|
|
September 30,
|
|||||||||
|
2010
|
2011
|
||||||||
|
RMB
|
RMB
|
||||||||
|
Prepaid lease
|
778 | 1,510 | |||||||
|
Deposits for purchase of acquired intangible assets
|
Note (i)
|
40 | 1,280 | ||||||
|
Deposits for purchase of plant and equipment
|
3,044 | 16,568 | |||||||
|
Others
|
20 | 282 | |||||||
| 3,882 | 19,640 | ||||||||
|
Note (i):
|
The Company entered into new technology transfer agreements with certain investors of new seed products and paid deposits
|
|
13.
|
BORROWINGS
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Short-term borrowings
|
85,900 | 20,000 | ||||||
|
14.
|
CONVERTIBLE NOTES
|
|
14.
|
CONVERTIBLE NOTES - Continued
|
|
15.
|
OTHER PAYABLES AND ACCRUED EXPENSES
|
|
September 30,
|
|||||||||
|
2010
|
2011
|
||||||||
|
RMB
|
RMB
|
||||||||
|
Payable for purchase of plant and equipment
|
99 | 206 | |||||||
|
Payable for purchase of land use rights
|
1,050 | 1,050 | |||||||
|
Payable for purchase of construction-in-progress
|
1,276 | 2,009 | |||||||
|
Professional fee payable
|
3,653 | 3,789 | |||||||
|
Salaries payable
|
12,633 | 8,192 | |||||||
|
Accrued staff bonus
|
1,757 | 1,757 | |||||||
|
Accrued interest
|
1,813 | 1,813 | |||||||
|
Accrued compensation expenses
|
177 | 150 | |||||||
|
Accrued other expenses
|
1,361 | 1,284 | |||||||
|
Other taxes payable
|
517 | 350 | |||||||
|
Deposits from growers
|
1,733 | 2,407 | |||||||
|
Payable for labor union and education expenses
|
721 | 677 | |||||||
|
Loans from employees of Denong
|
Note (i)
|
310 | 310 | ||||||
|
Loans from third parties
|
Note (ii)
|
3,600 | 3,600 | ||||||
|
Payable to former owners of Kunfeng
|
2,660 | 2,060 | |||||||
|
Deferred government subsidies
|
Note 16
|
- | 8,526 | ||||||
|
Others
|
2,296 | 2,171 | |||||||
| 35,656 | 40,351 | ||||||||
|
Note(i):
|
RMB310 was borrowed from employees of Denong with interest of 12.5% per annum at the years ended September 30, 2010 and 2011.
|
|
Note(ii):
|
RMB3,600 was borrowed from third party companies with interest free, unsecured and have no fixed repayment terms at the years ended September 30, 2010 and 2011.
|
|
16.
|
OTHER LONG-TERM LIABILITIES
|
|
17.
|
SHARE OPTION PLAN
|
|
17.
|
SHARE OPTION PLAN - Continued
|
|
17.
|
SHARE OPTION PLAN – CONTINUED
|
|
Tranche 1
|
Tranche 2
|
Tranche 3
|
Tranche 4
|
Tranche 5
|
Tranche 6
|
|||||||||||||||||||
|
Grant date
|
November 8,
2005
|
October 22,
2007
|
March 28,
2008
|
June 16,
2008
|
January 4,
2010
|
January 3,
2011
|
||||||||||||||||||
|
Options outstanding as of October 1, 2009
|
214,120 | 20,000 | 315,167 | 10,000 | - | - | ||||||||||||||||||
|
Number of options granted
|
- | - | - | - | 125,000 | |||||||||||||||||||
|
Options exercised
|
(124,720 | ) | - | (154,000 | ) | - | - | - | ||||||||||||||||
|
Options cancelled/ forfeited/ expired
|
(25,000 | ) | (15,000 | ) | (5,000 | ) | - | - | - | |||||||||||||||
|
Options outstanding as of September 30, 2010 and October 1, 2010
|
64,400 | 5,000 | 156,167 | 10,000 | 125,000 | - | ||||||||||||||||||
|
Number of options granted
|
- | - | - | - | - | 120,000 | ||||||||||||||||||
|
Options exercised
|
(64,400 | ) | - | (26,000 | ) | - | - | - | ||||||||||||||||
|
Options cancelled/ forfeited/ expired
|
- | - | - | - | (5,000 | ) | - | |||||||||||||||||
|
Outstanding as of September 30, 2011
|
- | 5,000 | 130,167 | 10,000 | 120,000 | 120,000 | ||||||||||||||||||
|
Options vested and exercisable
|
||||||||||||||||||||||||
|
At September 30, 2010
|
64,400 | - | 156,167 | 10,000 | - | - | ||||||||||||||||||
|
At September 30, 2011
|
- | - | 130,167 | 10,000 | 120,000 | - | ||||||||||||||||||
|
Weighted average fair value at the grant date (USD)
|
2.69 | 4.55 | 2.69 | 3.42 | 7.20 | 6.08 | ||||||||||||||||||
|
Tranche
1#
|
Tranche
2
|
Tranche
3*
|
Tranche
4
|
Tranche
5
|
Tranche
6
|
|||||||||||||||||||
|
Exercise price (USD)
|
8.75 | 9.27 | 5.30 | 6.64 | 12.23 | 10.84 | ||||||||||||||||||
|
Average risk-free interest rate
|
4.47 | % | 4.08 | % | 2.51 | % | 3.73 | % | 1.66 | % | 1.03 | % | ||||||||||||
|
Expected option life (year)
|
3.5 | 3.8 | 2.7 | 2.9 | 3 | 3 | ||||||||||||||||||
|
Volatility rate
|
30.79 | % | 60.86 | % | 78.17 | % | 77.27 | % | 92.81 | % | 88.03 | % | ||||||||||||
|
Dividend yield
|
- | - | - | - | - | - | ||||||||||||||||||
|
|
#
|
Tranche 1 had been modified on September 14, 2009. The exercise price modified to USD 4.00 and the fair value was USD 2.66 at the modified date.
|
|
|
*
|
Tranche 3 consists of different vesting structures. The expected option life and fair value presented above are weighted average numbers.
|
|
17.
|
SHARE OPTION PLAN – CONTINUED
|
|
18.
|
TREASURY STOCK
|
|
19.
|
INCOME TAXES
|
|
19.
|
INCOME TAXES – Continued
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Current
|
580 | 4,046 | 6,991 | |||||||||
|
Deferred
|
11,152 | 5,273 | 6,739 | |||||||||
| 11,732 | 9,319 | 13,730 | ||||||||||
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Non-current deferred tax assets:
|
||||||||
|
Net operating loss carry forward
|
18,091 | 20,928 | ||||||
|
Impairment on inventory
|
3,935 | 3,634 | ||||||
|
Others
|
3,290 | 3,498 | ||||||
|
Non-current deferred income tax assets
|
25,316 | 28,060 | ||||||
|
Valuation allowances
|
(15,550 | ) | (25,032 | ) | ||||
|
Net non-current deferred income tax assets
|
9,766 | 3,028 | ||||||
|
Year ended
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Calendar year ending,
|
||||||||
|
2012
|
11,694 | 11,694 | ||||||
|
2013
|
53,698 | 25,586 | ||||||
|
2014
|
- | 188 | ||||||
|
2015
|
10,400 | 11,042 | ||||||
|
Tax losses that can be carried forward indefinitely
|
- | 45,944 | ||||||
| 75,792 | 94,454 | |||||||
|
19.
|
INCOME TAXES – Continued
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
%
|
%
|
%
|
||||||||||
|
Statutory rate
|
25 | 25 | 25 | |||||||||
|
Effect of preferential tax treatment
|
34 | (10 | ) | (550 | ) | |||||||
|
Effect of different tax jurisdiction
|
(157 | ) | 4 | 307 | ||||||||
|
Permanent book-tax difference
|
25 | - | 403 | |||||||||
|
Effect of changes of applicable tax rate
|
- | - | - | |||||||||
|
Change in valuation allowance
|
(80 | ) | (5 | ) | 998 | |||||||
|
Under (over) provision in prior year
|
38 | (2 | ) | 256 | ||||||||
|
Effective income tax rate
|
(115 | ) | 12 | 1,439 | ||||||||
|
20.
|
INCOME (LOSS) PER SHARE
|
|
Year ended
September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Net income (loss) (numerator), basic and diluted
|
(40,817 | ) | 49,053 | (23,079 | ) | |||||||
|
Shares (denominator):
|
||||||||||||
|
Common stock outstanding
|
23,013,692 | 23,292,412 | 23,382,812 | |||||||||
|
Weighted average common stock outstanding used in computing basic income per share
|
23,013,692 | 23,189,464 | 23,072,895 | |||||||||
|
Add: Share options
|
- | 147,801 | - | |||||||||
|
Weighted average common stock outstanding used in computing diluted income per share
|
23,013,692 | 23,337,265 | 23,072,895 | |||||||||
|
Net income (loss) per share-basic
|
RMB(1.77
|
) |
RMB2.12
|
RMB(1.00
|
) | |||||||
|
Net income (loss) per share-diluted
|
RMB(1.77
|
) |
RMB2.10
|
RMB(1.00
|
) | |||||||
|
21.
|
EMPLOYEE BENEFIT PLAN AND PROFIT APPROPRIATION
|
|
22.
|
COMMITMENTS AND CONTINGENCIES
|
|
|
(a)
|
Capital commitments
|
|
September 30,
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
Equipment
|
5,251 | 9 | ||||||
|
Plant and building construction
|
5,362 | 15,353 | ||||||
|
Technology use right
|
1,210 | 730 | ||||||
|
Project of gene modification
|
5,000 | 5,000 | ||||||
| 16,823 | 21,092 | |||||||
|
|
(b)
|
Operating lease
|
|
RMB
|
||||
|
Year ending September 30,
|
||||
|
2012
|
2,354 | |||
|
2013
|
1,956 | |||
|
2014
|
1,170 | |||
|
2015
|
1,139 | |||
|
2016
|
1,133 | |||
|
Thereafter
|
6,881 | |||
| 14,633 | ||||
|
22.
|
COMMITMENTS AND CONTINGENCIES – Continued
|
|
|
(c)
|
Contingent tax liabilities
|
|
23.
|
FAIR VALUE OF FINANCIAL INSTRUMENTS
|
|
24.
|
SEGMENT AND GEOGRAPHIC INFORMATION
|
|
25.
|
OPERATING RISK
|
|
25.
|
OPERATING RISK - Continued
|
|
26.
|
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
|
|
September 30
|
||||||||
|
2010
|
2011
|
|||||||
|
RMB
|
RMB
|
|||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
4,995 | 1,099 | ||||||
|
Other receivables
|
189 | 118 | ||||||
|
Acquired intangible assets, net
|
5 | 1 | ||||||
|
Due from inter-companies
|
144,249 | 136,796 | ||||||
|
Total current assets
|
149,438 | 138,014 | ||||||
|
Investment in unconsolidated subsidiaries
|
166,542 | 165,522 | ||||||
|
Total assets
|
315,980 | 303,536 | ||||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current liabilities
|
||||||||
|
Due to related parties
|
1,592 | 1,509 | ||||||
|
Other payables and accrued expenses
|
3,444 | 3,931 | ||||||
|
Income tax payable
|
39,059 | 39,059 | ||||||
|
Total current liabilities
|
44,095 | 44,499 | ||||||
|
Total stockholders’ equity
|
271,885 | 259,037 | ||||||
|
Total liabilities and stockholders’ equity
|
315,980 | 303,536 | ||||||
|
26.
|
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY - Continued
|
|
Year ended September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Cost of revenues
|
(494 | ) | (208 | ) | (21 | ) | ||||||
|
Operating expenses
|
||||||||||||
|
Selling and marketing
|
(992 | ) | (295 | ) | (29 | ) | ||||||
|
General and administrative
|
(9,388 | ) | (11,058 | ) | (11,596 | ) | ||||||
|
Research and development
|
(272 | ) | (146 | ) | (32 | ) | ||||||
|
Changes in the fair value of embedded derivatives
|
3,300 | - | - | |||||||||
|
Loss on repurchase of convertible notes
|
(51,101 | ) | - | - | ||||||||
|
Other expenses, net
|
(20 | ) | - | - | ||||||||
|
(Loss) from operations
|
(58,967 | ) | (11,707 | ) | (11,678 | ) | ||||||
|
Equity in earnings of unconsolidated subsidiaries
|
23,283 | 60,507 | (11,402 | ) | ||||||||
|
Interest income
|
77 | 253 | 1 | |||||||||
|
Interest expense
|
(5,210 | ) | - | - | ||||||||
|
Profit (loss) before income taxes
|
(40,817 | ) | 49,053 | (23,079 | ) | |||||||
|
Income tax expense
|
- | - | - | |||||||||
|
Net profit (loss)
|
(40,817 | ) | 49,053 | (23,079 | ) | |||||||
|
Year ended September 30,
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
RMB
|
RMB
|
RMB
|
||||||||||
|
Net cash provided by/(used in) operating activities
|
(28,433 | ) | 108,012 | (3,745 | ) | |||||||
|
Net cash provided by/(used in) financing activities
|
21,781 | (106,493 | ) | 7,292 | ||||||||
|
Net increase/(decrease) in cash and cash equivalents
|
(6,652 | ) | 1,519 | 3,547 | ||||||||
|
Cash and cash equivalents, beginning of year
|
12,209 | 6,245 | 4,995 | |||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
688 | (2,769 | ) | (7,443 | ) | |||||||
|
Cash and cash equivalents, end of year
|
6,245 | 4,995 | 1,099 | |||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|